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ABSTRACT 
 
 Depression is a serious psychiatric disorder characterized by a range of 
debilitating symptoms. Long-term exposure to stress is a significant risk factor for 
the onset and maintenance of depression. Rats exposed to repeated treatment 
with the stress hormone corticosterone (CORT), a well-established rodent model 
of depression, begin to display depression-like symptoms. The development of 
depression-like symptoms with prolonged exposure to CORT is accompanied by 
reductions in the number and maturation rate of immature dentate granule cells 
within the hippocampus. Furthermore, these changes are paralleled by gradual 
decreases in reelin-expressing cells in the dentate subgranular zone of the 
hippocampus. Reelin is a large extracellular matrix protein that has been 
implicated in a number of neuropsychiatric disorders, including szchiphrenia, 
bipolar disorder, autism, as well as major depression. It holds important roles in 
learning and memory, cell migration and integration, synaptic contact formation, 
and adult neurogenesis. Mice deficient in reelin are more susceptible to CORT-
induced impairments in hippocampal neurogenesis and the development of a 
depressive phenotype. Previous work has shown that intra-hippocampal infusions 
of reelin into the hippocampus reverse CORT-induced increases in depression-
like behavior in rats, while restoring accompanying impairments in hippocampal 
neurogenesis.  
Reelin is also expressed in peripheral organs and tissues, though its roles 
here are not well understood. However, reelin-deficient mice show peripheral 
alterations in the clustering pattern of the serotonin transporter (SERT) in 
membranes of blood lymphocytes. The serotonin transporter is one of the main 
targets of antidepressant action, and importantly, this altered pattern of SERT 
clustering in reelin-deficient mice is mirrored both in patients with depression and 
in rats exposed to prolonged CORT treatment.  
Based on the previous findings, we were motivated to examine whether 
peripheral injections of reelin could restore CORT-induced increases in 
depression-like behavior. To investigate possible mechanisms, we examined (i) 
 iii 
 
the SERT clustering pattern in peripheral lymphocyte membranes, and (ii) the 
maturation rate of immature hippocampal neurons.   
40mg/kg of CORT was administered subcutaneously once per day for 21 
consecutive days. In conjunction, we utilized a novel reelin injection paradigm, 
where reelin was delivered via the lateral tail vein at either 3µg/ml or 5µg/ml every 
5 or 10 days during the period of CORT injections. Depression-like behavior was 
measured using the forced swim test the day following the last CORT injection. 
The open field test was included as a measure of locomotive and anxiety-like 
behavior.  
Importantly, peripheral reelin at all dosages administered restored CORT-
induced increases in depression-like behavior in the forced swim test, normalizing 
both immobility and swimming behaviors. Neither CORT nor reelin impacted open 
field behavior. As expected, CORT-treated rats displayed alterations in SERT 
membrane protein clustering, and importantly this was restored by all doses of 
reelin administered. Peripheral reelin did not significantly reverse the CORT-
induced deficits in immature neuron maturation rate.  
These novel findings demonstrate that reelin has antidepressant-like 
actions when given peripherally and provide evidence for the regulation of 
serotonin transporter clustering in lymphocyte membranes as a mechanism for 
the antidepressant action of reelin.  
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CHAPTER 1 
General Introduction 
 
1. Introduction to Depression and Stress as a Predisposing Factor for the 
Onset and Maintenance of Depression  
 
1.1 Depression 
Major Depressive Disorder (MDD) is a debilitating psychiatric disorder with a 
lifetime prevalence rate of 15-30% (Kessler et al., 2003). It is estimated by the 
World Health Organization (WHO) that MDD will be the leading cause of disease 
burden worldwide by 2030 (Willner et al., 2013). MDD presents as a complex and 
highly heterogeneous disorder with regard to its symptoms (McGlinchey et al., 
2006). It is characterized by a range of disabling symptoms, that include low 
mood, mood variability, anhedonia (loss of pleasure or interest), impairments in 
emotion regulation, disrupted sleep and appetite, low energy and motivation, 
suicidal ideation, and altered cognitive attributes such as rumination, impaired 
attentional control, and dysfunctional attitudes (Fales et al., 2007; Fava & 
Kendler, 2000; Ramel, Goldin, Carmona, & McQuaid, 2004). Not surprisingly, 
these symptoms can present as serious challenges and setbacks in an 
individual’s daily living. To fit the diagnostic criteria for MDD, an individual must 
present with at least 5 of the following symptoms, nearly every day, for at least 2 
weeks, of which at least one of the symptoms must be (1) depressed mood or (2) 
anhedonia.  
(1) Depressed or irritable mood most of the day, as indicated through 
subjective report or observations made by others 
(2) Reduced interest/pleasure in most or all activities, most of each day (as 
made by subjective report or observation) 
(3) Significant weight change, or change in appetite  
(4) Change in sleep (insomnia or hypersomnia)  
(5) Change in activity level (psychomotor agitation or retardation); made 
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through observation and not merely subjective evaluation 
(6) Fatigue or loss of energy 
(7) Feelings of worthlessness or excessive/inappropriate guilt 
(8) Diminished ability to think or concentrate 
(9) Suicidal ideations. 
In addition, the depressive episode cannot be attributed to the physiological 
effects of a substance or another medical condition, or be better explained by the 
diagnosis of another mood or psychotic disorder. There must be no prior history 
of a manic or hypomanic episode (American Psychiatric Association, 2013).  
Despite both the severity and ubiquity of major depressive disorder, there still 
remains a lack of understanding about the neurobiological mechanisms that 
underlie its development and recurrence. Since the initial discovery and 
development of monoamine oxidase inhibitors (MAOIs) and tricyclic 
antidepressants (TCAs), the pathophysiology of depression has been largely 
dominated by the monoamine hypothesis (Hindmarch, 2002). According to the 
monoamine hypothesis of depression, decreased neural transmission of the 
cerebral monoamines, which include serotonin, dopamine, and norepinephrine, 
underlie depressive pathology. However, the monoamine hypothesis alone 
cannot entirely explain the pathophysiology of depression or the action of 
common serotonergic and noradrenergic antidepressants, given that there is an 
appreciable delay period between antidepressant regulation of monoamine 
availability and therapeutic outcomes (Hindmarch, 2002; Sanacora et al., 2012), 
suggesting that the antidepressant effects are due to events occurring 
downstream of monoamine regulation. Other biological theories exist that attempt 
to explain the pathophysiology of depression, which include theories of: 
dysregulated hypothalamic-pituitary-adrenal (HPA) axis functioning, reduced 
hippocampal volume, and compromised immune functioning related to the 
secretion of pro-inflammatory cytokines (Post, 1992; Sapolsky, 2000; Maes, 
2001; Maes et al., 2009; Raison et al., 2006; Miller et al., 2009; Blume et al., 
2011; Young et al., 2014).  
Despite the relative short-term effectiveness of pharmacological and 
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psychological treatments for depression, there is a continued need for the 
development of fast-acting and effective long-term treatments in order to address 
the current large-scale treatment resistance experienced by many patients 
(Marchetti, Koster, Sonuga-Barke, & De Raedt, 2012). This need stems from the 
complicated nature of treatment development in the field of depression due to the 
complex etiology of the disorder. Heritability of depression based on twin studies 
is estimated at 40-50% (Levinson, 2006). However, in addition to genetic pre-
determinants, there are potent environmental factors, such as early life trauma 
and recent stressful experiences, which inarguably come into play when 
determining the influencing factors that contribute to the development of 
depression (Checkley, 1996; Parker et al., 2003; Kendler et al., 2002, 2004). 
Additionally, there exists substantial variability in stress susceptibility among 
individuals, making it more or less likely for some individuals to confer stress 
resilience than others.  
 
1.2 Structural and Functional Alterations in Depression 
Although the monoamine hypothesis dominated the field of depression for 
many years, more recent research has elucidated prominent changes in the 
structure, function, and responsiveness of the brain associated with depressive 
disorder (Berton & Nestler, 2006; Pittenger & Duman, 2008). The 
pathophysiology of depression is increasingly being studied in relation to the 
neural circuitry involved in the interactions between emotional and attentional 
processes, contributing to an understanding of depression as a failure to employ 
top-down attentional processes to manage limbic activity (Farb, Segal, & 
Mayberg, 2007; Drevets, 2000; Marchetti et al., 2012). Neuroimaging of patients 
experiencing a depressive episode has revealed a profile of brain metabolic 
changes that reflect abnormal activation of various brain structures involved in 
emotion regulation and stress response (e.g., hippocampus and amgydala). For 
instance, individuals with major depression show hyperactivity of the amygdala 
when processing emotionally-laden information (Sheline et al., 2001). In contrast, 
other brain regions involved in sensory processing and attention, such as the 
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dorsolateral prefrontal cortex (DLPFC), are aberrantly deactivated (Drevets, 
2001). Increased number of depressive episodes has been associated with 
reduced connectivity between frontal and limbic areas, supporting the idea for a 
disruption of network circuitry involved in top-down cognitive control over limbic 
activity in depression (Dannlowski et al., 2009). 
In addition to the abnormal activation of various brain regions, neuroimaging 
and post-mortem analyses in patients with depression have revealed structural 
alterations in limbic and forebrain regions, including the hippocampus, amygdala, 
and prefrontal cortex (Drevets, 2000, 2001; Jaracz, 2008). Of these regions, the 
hippocampus has been the most extensively studied in the context of depression. 
The hippocampus plays a central role in long-term potentiation (LTP), in the 
consolidation of short-term memory into long-term memory, and in spatial 
memory, and consequently, navigation. A simplified description of hippocampal 
neuroanatomy and neuro-circuitry will be given in the following paragraph in 
order to provide a brief introduction to the unique characteristics of the 
hippocampal formation.  
The hippocampus is part of the broader hippocampal formation, which is 
comprised of the: hippocampus proper, dentate gyrus, subiculum, presubiculum, 
parasubiculum (together making up the subicular cortex), and the entorhinal 
cortex (EC). The hippocampus proper is made up of the Cornu Ammonis (CA) 
which consists of three subfields making up the hippocampal circuit: CA1, CA2, 
CA3. The passage of information through intrahippocampal circuits is largely 
unidirectional, a unique feature of hippocampal neuroanatomy. First, cells in the 
superficial levels of the entorhinal cortex have axons that extend primarily to the 
dentate gyrus, in a unidirectional manner. It is these axonal projections from the 
entorhinal cortex to the dentate gyrus that form the perforant pathway - a major 
input pathway into the hippocampus. Next, granule cells, the primary cells of the 
dentate gyrus, project mossy fiber axons to the pyramidal cells of the CA3 
hippocampal field. Pyramidal CA3 cells then project to the CA1 hippocampal field 
via Schaffer collateral axons. The CA2 field is a narrow zone of cells located 
between CA3 and CA1 fields. It has large pyramidal cells like CA3, but unlike 
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CA3 it is not innervated by mossy fibers from the dentate gyrus. Following 
innervation by CA3 Schaffer collaterals, CA1 pyramidal cells then project to the 
subiculum, affording the main source of excitatory input to the subiculum. In all 
cases, these projections create a unidirectional course for information flow. 
Pyramidal cells of the CA1 hippocampal field also project to the entorhinal cortex. 
As well, the subiculum projects primarily to the entorhinal cortex. It is through 
these connections back to the entorhinal cortex, that both the CA1 field and the 
subiculum close the hippocampal circuitry loop that began in the superficial 
layers of the entorhinal cortex (Amaral & Lavenex, 2007).  
The laminar organization of the hippocampus is similar for all of its major 
fields. The stratum oriens is the deepest, or most subficial layer of the CA, 
located superficial to the alveus, which borders the wall of the lateral ventricle. 
This description is based on conventional superficial-deep nomenclature, which 
defines regions closer to the pia or hippocampal fissure as superficial and those 
regions in the opposite direction (closer to the alveus) as deep. The basal 
dendritic tree of pyramidal cells extends into the stratum oriens. Superficial to the 
stratum oriens is the stratum pyramidal layer, which is the principal cell layer and 
is most tightly packed in CA1. Superficial to the stratum pyramidal layer is the 
stratum radiatum, which contains interneurons that form inhibitory and excitatory 
contacts, as well as the CA3 to CA1 Schaffer collaterals. Next, is the stratum-
lacunosum-moleculare (SLM), the most superficial layer of the hippocampus 
proper. Like the stratum radiatum, the SLM contains a variety of interneurons. 
Fibers from the entorhinal cortex and afferent fibers from other regions also 
terminate in the SLM. The dentate gyrus is a three-layered cortical structure, 
characterized by its U shape. Its most superficial layer, residing closest to the 
hippocampal fissure, is the molecular layer, containing relatively few cells. The 
principal cell layer of the dentate gyrus is the granule cell layer (GCL), which is 
made up of densely packed excitatory granule cells, whose apical dendrites 
extend into the superficial portion of the molecular layer. The U shape created by 
the molecular layer and the GCL surrounds the polymorphic cell layer, which is 
also referred to as the hilus. The hilus contains inhibitory interneurons as well as 
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the mossy fiber axons of granule cells that extend to the CA3 field. (Amaral & 
Lavenex, 2007). Importantly, between the GCL and the hilus is the subgranular 
zone (SGZ), which is one of the few sites in the adult brain where new neuron 
birth takes place. This important region will be discussed in more detail later on.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. Representation of the laminar organization and connectivity of the rodent 
hippocampal formation. Adapted from Lebedeva (2017), with permission.   
 
While there exists obvious hippocampal differences between species, for 
example significantly greater hippocampal volumes and more complex 
hippocampal organization in primates as compared to rodents, the basic 
hippocampal architecture and the pattern of connectivity just described are 
similar in rats, monkeys, and humans. It is these similarities that allow for cross-
species inferences to be made when elucidating various structural and functional 
brain abnormalities associated with a range of psychiatric disorders.  
CA2 
Alveus 
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As mentioned, the hippocampus has received extensive focus in depression 
research. Hippocampal volume reductions are associated with depressive illness, 
with more pronounced reductions observed with increased severity and duration 
of the disorder (MacQueen et al., 2003; Caetano et al., 2004; Campbell et al., 
2004; Frodl et al., 2004, 2006; Jaracz, 2008; Lorenzetti et al., 2009). Reduced 
PFC volumes have also been observed in patients with depression (Konarski et 
al., 2008), whereas amygdalar volume appears to change from an initial increase 
in size at onset of illness to a reduction in volume with progression of the disorder 
(Lorenzetti et al., 2009). Notably, these brain regions that show structural 
alterations associated with depression (i.e., hippocampus, PFC, and amygdala), 
are part of the limbic-cortico-thalamic circuit, which regulates attentional control 
of emotional processing, and has been implicated in depressive pathophysiology 
(Farb et al., 2007; Segal & Mayberg, 2007; Drevets, 2000; Marchetti et al., 2012). 
Collectively, these brain regions are involved in cognition and emotion regulation, 
and the shared dysregulation in their structure and function may lead to 
impairments in emotion, motivation, cognition, and behavior that characterize 
mood disorders.  
 
1.3 The HPA Axis: Relation to Stress and Depression 
The hippocampus is also involved in stress adaptation and resilience, which 
can pose environmental contributing factors for the onset and development of 
psychiatric and mood disorders. Stress may be defined as a physiological 
adaptation to environmental challenges or threats that cause activation of the 
hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis comprises a complex 
set of interactions among three endocrine glands, the hypothalamus, pituitary 
gland, and adrenal glands. The HPA system regulates many body processes. It 
is involved in homeostasis, digestion, immune response, mood and emotions, 
energy storage and expenditure, and regulation of the stress response. The 
normal response to a stressful event is the engagement of the HPA axis, 
resulting in the subsequent release of corticosteroid hormones into systemic 
circulation (de Kloet et al., 1998). This stress response begins with the release of 
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corticotrophin releasing hormone (CRF) from the paraventricular nucleus (PVN) 
of the hypothalamus. CRF then acts on the anterior pituitary gland to release 
adreno-corticotrophin releasing hormone (ACTH) into the circulatory system. 
ACTH reaches the adrenal glands where it stimulates the release of 
glucocorticoids (cortisol in humans and corticosterone in rodents) from the 
adrenal cortex into the circulatory system. This cumulative elevation in levels of 
circulating glucocorticoids acts on bodily tissues to mobilize resources to 
essential functions and limit the activity of non-essential functions, ultimately 
allowing an organism to adapt to the stressful situation.  
In addition to exerting their effects on peripheral organs and tissues, 
corticosteroid hormones also act on localized regions of the brain containing two 
main subtypes of receptors. The mineralcorticoid receptor (MR) has a high 
affinity for both aldosterone and corticosterone; thus, these receptors are 
activated even at low levels of circulating CORT. The glucocorticoid receptor 
(GR) holds about ten times less affinity for corticosterone than the MR. For this 
reason, the GR is less activated than the MR under conditions of low circulating 
stress hormone. However, at peak circadian rhythm or following stress exposure, 
the GR will become markedly activated (de Kloet et al., 1998). The GR is more 
widely distributed throughout the brain than the MR; however, both types are 
present in the CA1 hippocampal field and in granule cells in the dentate gyrus 
(DG). With this concentration of GR and MRs in the hippocampus, it is not 
surprising that the hippocampus is particularly susceptible to the deleterious 
effects of chronic stress (Herman et al., 1995; Drevets, 2001; McEwen, 2005, 
2007), as GRs in the hippocampus play a critical role in regulating stress 
responses through negative feedback control of the stress system (de Kloet et 
al., 1998). Additionally, the GR remains concentrated in the PVN of the 
hypothalamus. GRs in the PVN of the hypothalamus receive complex signals 
from many regions of the brain (NE+, E+/-, GABA-, 5-HT+/-, Ach+, alpha, beta). 
The PVN integrates these signals, and when necessary will stimulate the 
cascade of glucocorticoid events, beginning with the release of CRF.  
As mentioned, these interactions of the HPA axis comprise a negative 
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feedback system in which elevated levels of cortisol/corticosterone act on GR 
and MR in the pituitary, hypothalamus, hippocampus, and various other regions 
throughout the brain to inhibit the further release of corticosteroids (Herman & 
Cullinan, 1997). These regions include the PFC and amygdala, which both 
express mineralcorticoid and glucocorticoid receptors, and participate in negative 
feedback control of the HPA axis. The hippocampus and PFC are typically 
involved in the inhibition of HPA axis activity, while the amygdala enhances HPA 
axis activity (Feldman et al., 1995; Herman and Cullinan, 1997; Jacobson and 
Sapolsky, 1991). When glucocorticoids activate hippocampal GR, projections 
from the ventral hippocampus activate GABAergic interneurons in the stria 
terminalis, and these then inhibit the production of CRF from the PVN of the 
hypothalamus (Anaker et al., 2011).  
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Fig 2. The hypothalamic-pituitary-adrenal axis. A cascade of events resulting in the 
cumulative release of glucocorticoids (i.e., cortisol/corticosterone) which travel via the 
bloodstream and act on GRs, as part of a negative feedback loop (shown by red arrows). 
Black block arrows represent the neural connections via which the hippocampus and 
amygdala affect the activity of the hypothalamus. 
 
In the case of persistently high levels of glucocorticoids, the integrity of GRs is 
jeopardized and the regular functioning of the HPA axis can become disrupted. In 
optimal conditions, when hippocampal GR numbers are high, feedback inhibition 
is efficient and the HPA axis is tightly regulated. However, when GR numbers in 
the hippocampus are low, feedback inhibition becomes inefficient, resulting in 
higher than normal levels of glucocorticoids (de Kloet et al., 1998). This resultant 
dysregulated glucocorticoid action has been shown to cause hippocampal 
remodeling and cell death, such as dendritic arbor retraction of CA3 pyramidal 
neurons, hippocampal volume loss, reduced number of corticosteroid receptors, 
decreased expression of hippocampal GR mRNA, and reduced hippocampal 
neurogenesis (Magarinos & McEwen, 1995; Herman et al., 1995; Sapolsky, Krey, 
& McEwen, 1992; McEwen, 2000a, 2005, 2007; Fuchs, 2007). This hippocampal 
damage as a result of elevated levels of stress hormones likely only serves to 
further disrupt HPA axis functioning, which in turn only exacerbates damage (de 
Kloet et al., 1998). It is important to note that the activation of the HPA axis 
following exposure to a stressor is an important mechanism that prepares an 
organism for survival (de Kloet et al., 1998). By contrast, prolonged activation of 
the HPA axis leads to negative health outcomes, and an important goal for 
research is to better understand the mechanisms by which it does so and how 
they can ultimately contribute to the development of depressive symptoms.  
Stress exposure has been linked to some of the volume changes in several 
brain regions seen in patients with depression. Hippocampal remodeling and cell 
death as a result of elevated levels of glucocorticoids have been suggested to 
contribute to the volumetric changes and ensuing pathological outcomes seen in 
depressed patients (Drevets, 2001; McEwen, 2007; Sapolsky, 2000). In line with 
this, there is evidence to support an association between hypersecretion of 
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cortisol, known as hypercortisolemia, and hippocampal, PFC, and amygdalar 
volume in patients with depression (Lorenzetti et al., 2009; Pariante, 2003; 
Pariante and Miller, 2001; Sheline, 2000). These hippocampal volume reductions 
are improved with correction of cortisol levels. Animal studies have shown that 
persistently high levels of glucocorticoids induce dendritic atrophy and 
sometimes cellular death in hippocampal and PFC regions, and dendritic 
hypertrophy in amygdalar regions (McEwen, 2007; Mitra & Sapolsky, 2008).  
A large body of clinical research has shown that exposure to stress can be an 
instigating factor in the development of depression. For instance, the onset of 
depression has been shown to correlate with major stressful life events such as 
divorce or the death of a loved one (Kessing, Agerbo, & Mortensen, 2003). 
Furthermore, a significant number of patients with depression (~ 50%) display 
hypercortisolemia (Gillespie & Nemeroff, 2005; Sachar & Baron, 1979), and this 
condition has been shown to be reversed with antidepressant treatment 
(Holsboer, 2001). Similarly, patients with Cushing’s syndrome, which is 
characterized by pathological hypercortisolemia, show significantly high rates of 
depression (Sonino & Fava, 2002). Moreover, several classes of effective 
antidepressant treatments function by influencing neuroendocrine control of 
cortisol secretion (Pariante et al., 2001, 2003; Pariante & Miller, 2001). Some 
patients with major depression show aberration in HPA axis function as 
evidenced by the dexamethasone suppression test. In healthy subjects, 
dexamethasone will bind to glucocorticoid receptors resulting in the inhibition of 
ACTH synthesis and consequently a suppression of cortisol release. However, 
some patients with depression do not show the expected stress response to this 
synthetic glucocorticoid (Southwick et al., 2005), due to a disrupted negative 
feedback loop that results in a failure to lower cortisol levels in response to 
dexamethasone. These abnormalities are partially normalized when clinical 
symptoms have been treated with pharmacotherapy, and some studies show that 
a failure to normalize is linked to poor symptom outcome and early relapse 
(Grenden et al., 1983). These correlations provide compelling evidence that 
elevated levels of stress hormones, or glucocorticoids, may lead to certain 
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aspects of depression (Sterner & Kalynchuk, 2010).  
Given the aforementioned research supporting a role for stress-related 
endocrine changes and neurobiological alterations of the limbic system in the 
pathological functioning seen in patients with depression, the question may be 
asked: does stress precede the onset of depression by altering certain brain 
structures and functions, and by what mechanisms does it do so? 
 
2. Animals Models to Study Depression 
 
2.1 Usefulness of Animal Models 
 Animal models hold an essential place in the study of many human 
psychiatric disorders, including in the examination of the link between stress and 
depression. Research with human patients is limited by concerns for ethical 
issues, and a constrained ability to precisely and independently manipulate 
variables in order to make causal inferences. For instance, with clinical 
correlational data alone, it is difficult to determine whether elevated cortisol levels 
seen in some patients with depression are a causal factor leading to 
development of the disorder, or merely a result of the disorder itself. Preclinical 
animal studies can address this limitation by allowing for strict variable control, 
such as control of confounding variables that influence gene-environment 
interactions, while it is difficult for human studies to do so. However, no animal 
model exists that can perfectly replicate the range of complex and varying 
aspects of human psychiatric disorders. Moreover, some depressive symptoms, 
such as suicidal ideations, can simply not be measured in animals. Yet, despite 
the complex phenotypes associated with depression and other psychiatric 
disorders, these disorders are also comprised of intermediate phenotypes that 
can be reproduced and evaluated in animals. These so-called intermediate 
phenotypes that can be modeled in rodents include behavioral, endocrinological, 
physiological and neuroanatomical alterations (Deussing, 2006). For instance, 
anhedonia, the loss of interest in a normally pleasurable activity, is a core 
symptom of depression that can be measured in rodents by evaluating 
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preference for an appetizing reward, such as sucrose. Disrupted functioning of 
the HPA axis, which is widely present in major depression, can be effectively 
measured in rodents using the dexamethasone suppression test. Lack of 
motivation and behavioral despair can also be evaluated in rodents using 
behavioral tests such as the forced swim test or the tail suspension test. 
Examination of physiological alterations in appetite, weight gain, and sleep levels 
that are associated with MDD, can also be measured in rodent models. Finally, 
neuroimaging research has elucidated the presence of hippocampal volume 
changes, specifically hippocampal volume loss, that present with major 
depression. Hippocampal volume changes have also been measured in animal 
models of depression that employ chronic stress paradigms, wherein rodents 
have been shown to exhibit similar reductions in hippocampal volume.  
However, in the examination of the aforementioned alterations common to 
both the human state of depression and those seen in animal models of 
depression, it is necessary to employ strict and established criteria in order to 
draw valid commonalities. In this vein, rodent models of depression must meet 
several measures of validity in order to be considered an adequate model. The 
model should (i) reasonably recapitulate the symptomology and neurobiology of 
the human disorder, or in other words, hold face validity, (ii) produce behavioral 
changes that can be measured objectively and systematically, (iii) produce 
behavioral alterations that can be restored by the same treatments that are 
effective in human patients, or in other words, hold predictive validity, (iv) be able 
to be reproduced in different laboratory settings, while holding replicability of 
results between investigators (Duessing, 2006; McKinney & Bunney, 1969), (v) 
be developed with reference to a rational theory that can be used to explain and 
answer questions about the etiology of the human disorder, or in other words, 
hold construct validity (Willner, 2005).  
 
2.2 Rodent Models of Depression 
There are various animal models that have been developed in order to study 
depressive etiology and symptomology, and the choice of which model to use will 
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largely depend on what aspects of the disorder one is attempting to study. Many 
animal models of depression employ a chronic stress paradigm in order to 
examine the behavioral and physiological consequences of chronic stress and 
the factors that contribute to the development of depression. Encompassed 
under animal models to study depression are those that employ either: (i) 
experimenter-induced stress, or (ii) exogenous CORT treatment. There are 
various experimenter-induced stress animal models that attempt to examine the 
influence of stress on the development of depression. Experimenter-induced 
stress falls under several different paradigms: (1) Chronic restraint stress, which 
has been widely used to study degeneration of specific brain regions as a result 
of stress, as well as explore stress-induced cognitive deficits associated with 
depression (Beck and Luine, 2002; Bowman et al., 2003; Conrad et al., 2003; 
Luine et al., 1994, 1996; Pham et al., 2003; Vyas et al., 2002, 2003; Watanabe et 
al., 1992b). However, there are some inconsistencies between studies in the 
range of behaviors it produces. For example, in regard to depression-like 
behavior, some studies have reported increased immobility on the forced swim 
test (FST) and a decreased preference for sucrose (Bravo et al., 2009; Joo et al., 
2009; Regenthal et al., 2009; Veena et al., 2009), whereas other studies have 
reported no effect on the FST (Gregus et al., 2005; Lussier et al., 2009; Perrot-
Sinal et al., 2004); (2) Chronic mild unpredictable stress (CMS), which 
incorporates a combination of psychosocial and physical stressors to reduce the 
chance of adaptation and to better simulate the variety of stressors encountered 
in daily life. Like the chronic restraint model, CMS also shows opposing 
behavioral results, but this may be due in part to difficulties in executing the 
model. Its ability to produce depression-like symptomology is still more robust 
than that of chronic restraint stress. CMS has been shown to lead to an increase 
in depression-like behavior (Willner et al., 1987; Willner, 2005), a decrease in 
neurogenesis, as well as signs of glucocorticoid overexposure, including 
increased adrenal weight, decreased thymus weight, decreased weight gain, and 
increased basal levels of cortisol (Herman et al., 1995; Cullinan & Wolfe, 2000; & 
Joëls et al., 2004). The model holds some disadvantages: it is rather labor 
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intensive, requires more space and resources, and often needs to be carried out 
over a longer period of time than other models (Kim and Han, 2006; Willner, 
1997, 2005); (3) Learned helplessness, which is sensitive to some 
antidepressants, but requires strong stressors; (4) Social stress: social defeat 
and social submissiveness, which have been shown to lead to reductions in 
neurogenesis.  
The aforementioned experimenter-applied stress models that employ 
environmental manipulations, while holding specific advantages, are also 
confounded by variations in the exact protocols used and difficulties in replication 
(Forbes et al., 1996; Vollmayr & Henn, 2001; Willner, 2005). Stressful stimuli 
used in these models can differ between animals in terms of their actual physical 
qualities and their perceived psychological qualities. These different responses 
can manifest in disparate CORT levels between rats exposed to the same 
stressor, leading to increased variability (Sterner & Kalynchuk, 2010). Another 
concern inherent to these models is the habituation effect that takes place when 
animals are repeatedly exposed to the same stressors (Galea et al., 1997; 
Gregus et al., 2005; Grissom et al., 2007). Such individual differences in stress 
response and adaptation that are characteristic of these models can also be 
regarded as advantageous in that they more closely resemble the individual 
differences in stress susceptibility and resilience present in the human 
population. However, for the purpose of producing reliable and vigorous 
symptomology that allows for the study of alterations in depression and its 
etiology, these models do not prove to be as beneficial. To address this need, the 
exogenous CORT model has been developed whereby CORT is administered 
exogenously for a period of weeks to months via subcutaneous injection, pellet 
implantation, osmotic pump infusion, or passive administration through drinking 
water or food. The exogenous CORT model has the benefit of isolating the 
effects of glucocorticoids from broader brain and circulatory effects that can 
result from environmental factors and confound the examination of how stress 
hormones directly affect the brain. Another advantage of the CORT model is its 
ability to produce a persistent depressive-like state in rodents, allowing for the 
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utilization of multiple behavioral tests following CORT wash-out. Additionally, the 
exogenous CORT model holds validity in that it has been shown to reproduce 
many of the core features of other stress models (Gourley & Taylor, 2009) and 
has been shown to be consistently replicable between laboratories. It maintains 
the ability to observe robust and reliable behavioral symptomology and 
neurobiological changes in the same animal, with fewer individual differences, 
when compared to other stress models (Sterner & Kalynchuk, 2010). 
Furthermore, the behavioral phenotype brought about by CORT is sensitive to 
reversal by chronic antidepressant treatment. In general, chronic antidepressant 
treatment increases neurogenesis and counteracts the effects of stress in both 
rodents and humans (Anaker & Hen, 2017).  
Various behavioral measures exist that are used to evaluate “depressive” 
symptomology in rodents brought about by stress induction and exogenous 
CORT treatment. These measures include weight loss, sleep disturbances, 
memory impairments, open field exploration, anhedonia, and behavioral despair. 
Anhedonia and learned helplessness, a form of behavioral despair, are the most 
frequently used measures to evaluate depression-like symptoms in rodents. 
Anhedonia, the lack of interest in pleasurable activities, is most often ascertained 
by measuring an animal’s preference for sucrose solution over water solution. 
Rats have a natural preference for sucrose, so a decrease in sucrose preference 
is thought to be indicative of a depressive state. Notably, antidepressants reverse 
this behavioral effect in anhedonic rats (Willner, 1997). There are several 
despair-based paradigms that are used to assess learned helplessness in rats, 
including the tail suspension test and the forced swim test (FST), but the FST is 
the most commonly used. The FST protocol first developed by Porsolt and 
colleagues (1977) included a pretest immersion trial followed by a subsequent 
immersion test. In this test, rats are placed in a container of water with no 
possibility of escape, and are forced to swim while their behavior is recorded for 
a period of time. During the test period, Porsolt found that the onset of immobility 
was much more rapid, which was interpreted to indicate “despair”, with the 
reasoning that the animal had realized escape was impossible. Increases in 
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passive immobility behavior and decreases in active swimming and struggling 
behavior are considered to be indicative of behavioral despair and a depressive 
phenotype (Lucki, 1997). The forced swim test holds strong predictive validity, 
because all forms of antidepressant treatment that are effective in humans 
decrease immobility behavior on this test (Cryan et al., 2005; Armario et al., 
1988; Porsolt et al., 1978). In fact, this test is often used as a screening tool for 
new antidepressants because there is a strong correlation between the clinical 
efficacy of antidepressants in humans and their potency on the forced swim test 
(Borsini & Meli, 1988; Castagne et al., 2011).  
 
2.3 Neurobiological and Behavioral Consequences of Repeated CORT Exposure  
 
2.3.1 Depression-like Behaviour  
There is a large body of literature evidencing that exogenous CORT treatment 
produces reliable and potent changes in various behaviors considered to be 
symptomatic of depression, evidencing the face validity of the model. Behavioral 
despair, which holds particular relevance to mood disorders, is one domain that 
exhibits potent effects as a result of CORT exposure. Specifically, rodents that 
are administered CORT via injection, pellet implantation, or in their drinking water 
show a decrease in their latency to immobility, increased time spent immobile, 
and decreased time spent swimming in the forced swim test (David et al., 2009; 
Gourley et al., 2008a; Gregus et al., 2005; Hill et al., 2003; Johnson et al., 2006; 
Kalynchuk et al., 2004; Marks et al., 2009; Murray et al., 2008; Zhao et al., 
2008b; Iijima et al., 2010). Importantly, the effects of CORT on depression-like 
behavior have been shown to be both dose and time dependent (Johnson et al., 
2006; Zhao et al., 2008b). For example, daily injections of 10, 20, 40 mg/kg of 
CORT for 21 consecutive days produces a progressive increase in depression-
like behavior on the FST (Johnson et al., 2006). Rats injected with 40mg/kg 
CORT consistently show increased immobility, decreased struggling, and a 
shorter latency to immobility than vehicle-injected rats, while rats that receive 
20mg/kg CORT show only a shorter latency to immobility, and 10mg/kg CORT-
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injected rats do not show any significant increases in depression-like behavior on 
any of the measures in the FST. CORT administered at 40mg/kg shows a linear 
progression on immobility behavior when measured at 7, 14, and 21 days, but 
only begins to reach significance at 14 days (Lussier et al., 2013). However, 
acute CORT treatment of only a single injection one day before testing has not 
been shown to have any effect on FST behavior (Johnson et al., 2006). Hence, 
these findings demonstrate that the amount of CORT, and the duration for which 
it is administered, have potent effects on behavioral measures indicative of a 
depressive phenotype (Sterner & Kalynchuk, 2010).  
As mentioned, anhedonia is commonly measured with the sucrose preference 
test. The CORT model holds induction validity for anhedonic behavior, while 
anhedonia measures themselves hold face validity. In various CORT paradigms, 
rodents show a reduction in sucrose preference (David et al., 2009; Gorzalka et 
al., 2003; Gourley et al., 2008a), as well as other anhedonic behaviors that 
include inhibited sexual and grooming behaviors (Gorzalka et al., 2001; Gorzalka 
and Hanson, 1998; Hanson and Gorzalka, 1999; David et al., 2009), and 
decreased food reinforcement response (Gourley et al., 2008a). The CORT 
model has been previously compared to 21 days of restraint stress at 6 hours per 
day. The CORT model shows stronger outcomes, evaluated in terms of body 
weight, sucrose preference, and immobility (Lussier et al., 2009). Significantly, 
many of the behavioral alterations following CORT administration are reversed 
with common antidepressant treatment, affirming the predictive validity of the 
CORT model of depression (David et al., 2009; Ago et al., 2008; Fenton et al., 
2015).  
 
2.3.2 Fear response in an open field 
Studies show mixed findings in regards to stress-induced or CORT-induced 
open field test behavior. Male rats exposed to 3 weeks of chronic mild stress 
have shown reduced exploration in the open field when tested 2 or 24 hours after 
the last stress exposure (Westenbroek et al., 2003; Westenbroek, Den Boer, & 
Ter Horst, 2003; Lin et al., 2008). Interestingly, female rats exposed to the same 
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paradigm have exhibited a different pattern of exploration in the open field 
compared to males, when tested 2 or 24 hours after the last stressor. Female 
rats showed increased exploration and distance travelled compared to males 
(Westenbroek, Den Boer, & Ter Horst, 2003; Westenborek et al., 2003; 
Westenbroek et al., 2005). Other research demonstrates no effect of CORT on 
open field exploration (Lussier et al., 2011; Kalynchuk et al., 2004; Brotto et al., 
2001; Gregus et al., 2005; Marks et al., 2009), only a sex difference with females 
exploring more (Kalynchuk et al., 2004), while still others show increased fear 
response (i.e., decreased exploratory behavior and increased freezing) in an 
open field following exogenous CORT administration (David et al., 2009; 
Skórzewska et al., 2006). 
 
2.3.3 Locomotor effects 
No differences have been observed between CORT and control rats in terms 
of the number of lines crossed in an open field test (Gregus et al., 2005), as well 
as no differences observed in a wire suspension test (Marks et al., 2009), which 
assesses muscle strength. Hence, CORT effects on behavior are likely not due 
to nonspecific motoric effects. 
 
2.3.4 Body weight 
CORT administration has been shown to affect changes in body weight gain 
(Barr et al., 2000; Brummelte et al., 2006; Bush et al., 2003; Coburn-Litvak et al., 
2003; Gregus et al., 2005; Johnson et al., 2006; Magarinos et al., 1998; Meijer et 
al., 1997), and changes in body weight are also seen in patients with depression. 
This effect is dose and time dependent. As the dose of CORT and duration of 
administration is increased, attenuated weight gain is seen over the course of 
treatment. However, CORT-treated animals have not been observed to 
physically eat less, suggesting that the attenuated effect of CORT on weight gain 
is not due to amount of food consumption, but rather is likely related to increased 
leptin levels. Nonetheless, the change in weight gain observed in the CORT 
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model represents a physiological parameter that is also altered in human 
depression, again lending face validity to the CORT model.  
 
2.3.5 Disrupted HPA axis function 
In addition to increased depression-like behavior, CORT administration also 
produces various physiological changes that are demonstrative of depression. 
One such change is dysregulated HPA functioning (Johnson et al., 2006). This 
disrupted stress response has been evaluated using FST as a novel stressor. 
When introduced to the FST, control animals show low basal levels of serum 
CORT, a normal peak of serum CORT 30 minutes after testing, and a return to 
normal levels 60 minutes after the test. However, animals treated with repeated 
CORT show higher basal levels of CORT, and do not show any CORT response 
following the forced swim novel stressor. This disrupted stress response 
remedies when CORT injections are halted for a period of two weeks. Acute 
CORT treatment has only a minimal effect on CORT response to a novel 
stressor.  
As briefly mentioned earlier, the PVN contains parvocellular neurons that 
produce CRF to act on the pituitary for the release of ACTH, and eventually 
cortisol/corticosterone release from the adrenal cortex. Parvocellular neurons 
receive GABAergic input from other hypothalamic nuclei, but also from the 
hippocampus (Herman & Cullinan, 1997). GABAergic input to parvocellular 
neurons is important for the regulation of parvocellular neuron activity (Cole & 
Sawchenko, 2002). Chronic stress has been shown to reduce GABAergic input 
to parvocellular neurons, while measured at low circulating corticosterone levels 
(Joëls et al., 2004). A GABAA receptor antagonist injected close to the PVN 
counteracts the inhibitory input to CRF-expressing cells, leading to an increase in 
CRF and circulating corticosterone levels (Cole & Sawchenko, 2002). The 
reduced GABAergic inhibition of CRF-expressing neurons following chronic 
stress may be one of the mechanisms by which CRF and, indirectly, basal CORT 
levels are enhanced following chronic stress. Neurogenesis may also be 
implicated in the stress response as it is glutamatergic projections from the 
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ventral DG of the hippocampus that activate the GABAergic inhibitory 
interneurons, which inhibit the neurons of the PVN. There is evidence implicating 
a role for neurogenesis in the maintenance of inhibitory control over the HPA 
axis, with reductions of neurogenesis further elevating levels of glucocorticoids 
and exacerbating reduced new neuron birth (Schloesser et al., 2009; Snyder et 
al., 2011). 
 
2.3.6 Hippocampal alterations 
Prolonged stress exposure has been documented to lead to a significant 
amount of structural remodeling in the adult brain, especially in the limbic system 
(McEwen, 2000b, 2007). These neurobiological alterations are proposed to 
underlie depressive pathology, and importantly, these alterations have been well 
defined using the exogenous CORT administration paradigm. CORT 
administration in rodents results in structural and functional consequences 
characterized by hippocampal volume loss, dendritic atrophy of hippocampal 
pyramidal cells, particularly in CA3 and CA1 apical dendrites (Magariños et al., 
1998, 1999; Sousa et al.,1998, 2000; Woolley et al.,1990), and loss of mossy 
fiber CA3 synapses (Sousa et al., 2000; Tata et al., 2006). This dendritic atrophy 
is similar to what has been observed in post-mortem tissue of patients with 
depression (Konarski et al., 2008). While these CORT effects are often not long-
lasting once exposure to the stressor has ceased, a high dose and/or extended 
administration of CORT can lead to hippocampal cell death (Sapolsky et al., 
1985). Similar alterations have been found using other chronic stress paradigms. 
Chronic stress drastically reduces synaptic plasticity in CA1 and DG hippocampal 
slices in vitro (Joëls et al., 2004) and in vivo (Gerges et al., 2001; Pavlides et al., 
2002). Chronic mild unpredictable stress for 21 days has been shown to result in 
reductions in CA3 surface area of pyramidal cells that does not return to control 
levels even after 3 weeks recovery. Decreased number of adult generated cells 
in the hilus, the SGZ, and in the total DG has also been observed after 3 weeks 
of CMS, showing only partial recovery after 3 weeks (Joëls et al., 2004). In 
contrast to the hippocampal atrophy observed following stress exposure and 
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CORT administration, repeated CORT treatment has been observed to cause 
dendritic hypertrophy in the amygdala (Mitra & Sapolsky, 2008).  
Neurogenesis in the hippocampus is another form of structural plasticity that 
has been associated with depression. Neurogenesis is defined as the generation 
of new neurons, a process that continues to occur throughout adulthood in the 
subgranular zone (SGZ) of the dentate gyrus. During the process of 
neurogenesis, newborn neurons in the SGZ migrate into the granule cell layer of 
the DG as they mature. They integrate into existing circuitry with dendrites 
extending into the molecular layer of the DG, and axons projecting to the CA3 
region of hippocampal pyramidal cells.  
Adult neurogenesis is a key function of the hippocampus that is sensitive to 
the negative effects of stress (Lucassen, 2015; Anacker, 2014). One of the initial 
reasons that neurogenesis became a focus in the context of depression was due 
to the observation that all known antidepressant treatments - antidepressant 
drugs, electroconvulsive shock, and physical activity - appear to increase the 
proliferation of newborn cells in the hippocampus (Malberg et al., 2000; Scott et 
al., 2000; van Praag et al., 1999; David et al., 2009). Notably, many chronic 
stress paradigms, including chronic CORT administration, have powerful effects 
on hippocampal neurogenesis in rodents (Fuchs & Gould, 2000; Pham et al., 
2003; Santarelli et al., 2003; Sapolsky, 2004; Sheline et al., 1999; Starkman et 
al., 1992; Surget et al., 2008, 2011; David et al., 2009; Wong & Herbert, 2006, 
2004; Tanti et al., 2013; Ramirez et al., 2015), and in non-human primates 
(Perera et al., 2011; Wu et al., 2014), as evidenced by rapid and potent 
decreases in the proliferation and survival of newborn cells. The attenuation of 
cell turnover and maturation of cells in the dentate gyrus following chronic stress 
may manifest in significant negative alterations in cell connectivity and 
hippocampal function, such as aberrant maturation and migration of cells in the 
dentate gyrus. This stress-induced suppression of cell proliferation has been 
shown to be restored by many different classes of antidepressant drugs in 
rodents (Czeh et al., 2001; Santarelli et al., 2003; Petrik et al., 2012; Surget et 
al., 2008; Malberg et al., 2000; Dagyte et al., 2010), non-human primates (Perera 
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et al., 2011), human post-mortem brain tissue (Boldrini et al., 2009, 2012), and in 
vitro in human hippocampal progenitor cells (Anacker et al., 2011).   
Stress has been shown to increase activity of the dentate gyrus in vivo, and 
stress and glucocorticoids increase DG synaptic currents in vitro (Shoenfeld et 
al., 2013; Karst & Joëls, 2003), suggesting that inhibition of DG activity holds 
relevance for stress-induced neurological disorders, including depression. 
Specifically, young neurons of the DG serve as potent inhibitors of DG granule 
cell activity under anxiogenic conditions, and therefore new neuron birth may 
affect behaviour through the modulation of neuronal networks that are involved in 
mood and anxiety and affect changes in the hippocampus (Anacker & Hen, 
2017). Consistent with this is the finding that blockade of GABA type A receptors 
in the ventral dentate gyrus prevent the anxiolytic effects of exercise (Shoenfeld 
et al., 2013). Furthermore, this inhibitory effect of immature DG neurons may be 
important for the process of cognitive flexibility – the erasing of previously 
established fear-associated memories to allow for the formation of new non-fear-
associated memories (Takahashi et al., 2008; Anaker & Hen, 2017). Ultimately, 
this may facilitate recovery from anxiety and depressive symptoms by supporting 
learning for the new context as safe rather than adverse.  
Together, these findings provide support for one of the foremost leading 
hypotheses relating to the etiology of depression - that chronic stress induces 
pathological remodeling of the hippocampus that leads to a decrease in 
neurogenesis and subsequent manifestation of depressive symptomology 
(Duman et al., 2000; Jacobs et al., 2000). Therefore, targeting neurogenesis may 
pose a promising avenue for combating stress susceptibility and eliciting 
antidepressant effects. This is particularly relevant given that adaptation to a 
stressful context is partially mediated by neurogenesis. Under basal conditions of 
(i) HPA axis activity; (ii) fear response; and (iii) innate levels of anxiety, despair 
and anhedonia, neurogenesis does not have an influence on behavior. However, 
when exposed to a stressful event, mice with high levels of neurogenesis show 
less of an increase in anxiety-like and depression-like behavior compared to mice 
that have inhibited neurogenesis, by way of transgenic or radiation methods 
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(Schloesser et al., 2009; Snyder et al., 2011). These neurogenesis-deficient mice 
also show a suppressed dexamethasone response compared to neurogenesis-
intact mice, supporting a role for the hippocampus in regulation of the HPA axis 
(Jankord & Herman, 2008). Once the stressful experience has dissipated, 
neurogenesis facilitates reversal learning and cognitive flexibility to aid 
adaptation and normal functioning in the environment once more, while reducing 
HPA axis hyperactivity (Mateus-Pinheiro et al., 2013)  
Despite findings that support the hypothesis of impaired adult neurogenesis in 
the pathophysiology of depression, there is in fact no direct evidence that 
decreased neurogenesis causes human depression. To the contrary, some post-
mortem evidence from patients with depression shows no significant reductions 
in neural stem cell proliferation and cell loss in the hippocampus (Muller et al., 
2001; Reif et al., 2006; Stockmeier et al., 2004; Lucassen et al., 2010). In animal 
models, depression-like symptoms and the restorative actions of antidepressants 
on behavior are not always concomitant with changes in hippocampal 
neurogenesis (Vollmayr et al., 2003; Surget et al., 2008; Bessa et al., 2009; 
David et al., 2009), calling into question a causal role for hippocampal 
neurogenesis in the pathophysiology of depression. In line with this, interruption 
of neurogenesis in rodents is not always concomitant with a depressive 
phenotype (Zhao et al., 2008a). Such findings challenge the hypothesis that 
reductions in hippocampal neurogenesis are a primary contributing factor in the 
development of depressive illness. Alternatively, the reductions in hippocampal 
volumes observed in post-mortem tissue of depressed patients may be 
attributable to reductions in the complexity of dendrites, rather than a deficit in 
the proliferation and survival of newborn neurons. To support this, Lussier and 
colleagues (2013) found that CORT gradually decreases the number and 
dendritic complexity of immature dentate gyrus neurons, surviving under 
conditions of elevated glucocorticoid levels, while also eliciting a depressive 
phenotype. It may also be the case that disruptions in neurogenesis contribute to 
the manifestation of only specific depressive symptoms. More research is 
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required to tease apart the influential role of hippocampal neurogenesis in 
depressive symptomology and antidepressant action.  
 
2.3.7 Disruption of spatial memory 
Depression is often associated with impaired cognition, with the most 
prominent deficits seen in verbal and spatial working memory (hippocampal 
dependent) and executive functioning. CORT administration has been shown to 
affect hippocampal dependent memory and executive functioning. CORT impairs 
object location memory and object-in-place memory (Brymer et al., in 
preparation). Moreover, cognitive deficits induced by CORT mirror those found in 
other preclinical models of depression, providing further support for the CORT 
paradigm as a model for studying depression (Sterner & Kalyncuk, 2010).  
 
To summarize, the CORT model demonstrates face, predictive, and construct 
validity. For instance, construct validity can be demonstrated by the effects of 
CORT on behavior, which do not appear to be solely a result of HPA axis 
disruption, since animals previously treated with CORT do not differ from controls 
in circulating CORT levels at testing (Gourley & Taylor, 2009). This effect mirrors 
that seen in human patients with depression and in CMS models. Exposure to 
CORT produces anhedonia, decreased sensitivity to reward (Gourley et al., 
2008a), and increased immobility in the FST (face validity), which represent a 
depressive phenotype and are sensitive to antidepressant treatment (predictive 
validity). 
 
3. Reelin as a Putative, Fast-acting Treatment for Depression 
 
3.1 Reelin 
In the context of stress and depression, recent research has focused on the 
activity of the large extracellular matrix glycoprotein, reelin. Reelin plays a critical 
role in neuronal migration and in the laminar organization of the CNS during 
embryonic development (D’Arcandelo et al., 1995; Gilmore & Herrup, 2000), as 
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well as holding important roles throughout adult life. Importantly, impairments in 
hippocampal plasticity produced by chronic stress and repeated CORT 
administration show high affinity with the biological activities of reelin. 
Reelin received its name from mice that were identified by scientists to 
display spontaneous mutations that manifested in difficulties with motor behavior. 
D.S. Falconer was the first to describe the “reeler” mouse in 1951, characterized 
by its abnormal reeling gate (Falconer, 1951). In the 1960s, histopathological 
studies showed that reeler mice had a cerebellum significantly decreased in size, 
and did not display the normal, ordered layering of several brain regions 
(Hamburgh, 1963). It was later discovered that these reeler mice were 
homozygous for mutation of the RELN gene encoding the reelin protein. This 
loss of reelin function through mutation of the RELN gene results in misguided 
neuronal positioning in the developing central nervous system. Mice that are 
heterozygous for the reelin gene, having 50% normal levels of reelin, do not 
display the same neuroanatomical defects, but do display hereditary 
characteristics that are linked to some psychotic disorders. In human patients, 
disruptions of the RELN gene have been found to cause a rare form of 
lissencephaly called Norman-Roberts syndrome (Crino, 2001; Chang et al., 
2007). The mutation results in low or undetectable amounts of the reelin protein 
that results in phenotypical characteristics of ataxia, hypotonia, (low muscle 
tone), developmental delay, and severe mental retardation. Throughout 
development and into adulthood, reelin is present not only in the brain, but in the 
spinal cord, blood, as well as in other bodily organs and tissues (Ikeda & 
Terashima, 1997; Smallheiser et al., 2000). 
3.1.1 Reelin in the CNS 
During brain development, reelin is secreted by Cajal-Retzius cells in the 
immature hippocampus and in the developing cerebral cortex (Meyer, Goffinet, & 
Fairen, 1999). By controlling cell-cell interactions, reelin plays an important role in 
the regulation of neuronal migration and positioning during brain development. 
Reelin affects the differentiation of progenitor cells into radial glia and orients the 
direction of their fibers, which guide the migrating neuroblasts (Hartfuss, Forster, 
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Bock, et al., 2003). Newborn neurons travel along radial glial fibers as they move 
towards their final destinations during development (Rakic, 2009). The layered 
positioning of reelin-secreting cells is important, since the orientation of radial 
glial fibers is determined by areas of higher reelin concentration (Nomura, 
Takahashi, Hara, & Osumi, 2008). To exemplify this importance, the specific 
connections formed in the layers of the hippocampus during development, and 
the determination of the compact granule cell layer, are regulated by reelin (Del 
Rio et al., 1997). Reelin protein has been hypothesized as a stop signal for 
migrating neuronal precursor cells. It is proposed to control their positioning by 
sending out a dissociation signal to neuronal groups, allowing them to use radial 
individual migration to reach their final position (Hack, Bancila, Loulier, et al., 
2002).  
Reelin is proposed to take part in the “NR2B to NR2A switch” that happens in 
early postnatal development (Liu, Murray, & Jones, 2004), and this may occur by 
increased mobility of NR2B-containing receptors as a result of reelin, thus 
reducing the amount of time they spend at the synapse (Sinagra et al., 2005; 
Groc et al., 2007). 
In the mature brain, reelin is expressed by GABAergic interneurons in 
corticolimbic structures of adult rodents and primates (Pesold et al., 1998, 1999; 
Guidotti et al., 2000) and by glutamatergic granule cells in the cerebellum 
(Pesold et al., 1998). Upon secretion in the extracellular matrix, reelin interacts 
with two members of the low density lipoprotein receptor gene family: 
apolipoprotein E receptor 2 (ApoER2) and very-low-density lipoprotein receptor 
(VLDLR), as well as alpha-3-beta-2 integrin receptors (D’Arcangelo et al., 1999). 
These receptors are present on both neurons and glial cells. Radial glia, which 
serve as primary progenitor cells and are capable of generating neurons, 
astrocytes, and oligodendrocytes (Noctor et al., 2001), contain the same amount 
of ApoER2, but ten times less VLDLR than neuronal or glial cells (Hartfuss et al., 
2003). These two receptors interact with the cytosolic adapter protein, Dab1, 
encoded by the Disabled-1 (Dab1) gene. DAB1 is a critical regulator of the reelin 
signaling cascade. Following the binding of reelin to cortical neurons, DAB1 
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binds to the intracellular part of VLDLR and ApoER2, to affect cell positioning in 
the developing brain and during adult neurogenesis in a signaling pathway 
downstream of RELN (Benhayon, Magdaleno, & Curran, 2003). In mice, targeted 
disruption of Dab1 results in a phenotype similar to that of the reeler mouse. 
 In adulthood, reelin continues to play important roles in neuronal migration 
and development. Reelin is highly active at the subventricular zone and the 
subgranular zone of the dentate gyrus. In some species, such as in rodents, 
reelin regulates the dissociation of neuroblasts from tangential to individual radial 
migration (Forster et al., 2006), after they have migrated from the subventricular 
zone to the olfactory bulb along the rostral migratory stream (RMS). In the adult 
dentate gyrus, reelin guides the continual migration and integration of immature 
neurons of the subgranular zone into the granule cell layer. 
Reelin participates in several other critical processes of adult brain 
functioning, including the modulation of synaptic plasticity through the induction 
and maintenance of long-term potentiation (D’Arcangelo, 2005; Weeber et al., 
2002), the regulation of learning and memory (Weeber et al., 2002), 
synaptogenesis, dendritic spine growth and density (Costa et al., 2002; Niu et al., 
2008; Chameau et al., 2009), hippocampal neurogenesis (Pujadas et al., 2010), 
and glutamatergic transmission, guiding the strength of glutamatergic synapses 
impinging on dendritic spines. The strengthening of LTP by reelin is due to the 
interaction of ApoER2 with the NMDA receptor, with the exon 19-containing 
variant of ApoER2 being produced more during periods of activity (Beffert et al., 
2005). The facilitation of dendrite growth by reelin is proposed to occur through 
Src family kinases, dependent upon the expression of Crk family proteins 
(Matsuki, Pramatarova, & Howell, 2008).   
The stratum lacunosum of the hippocampus has a high level of diffuse 
reelin immunoreactivity. Here, reelin is released by stratum lacunosum 
GABAergic interneurons and perforant pathway terminals that impinge onto the 
distal region of CA1 pyramidal dendrites. Reelin release in the stratum 
lacunosum is thought to regulate synaptic spine development and contribute to 
the induction of LTP. In the SGZ, GABAergic cells expressing reelin make 
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contacts with granule cell somata, regulating the migration and maturation of 
newborn granule cells. In vitro, addition of recombinant reelin to cortical 
synaptosomes has been shown to increase membrane protein expression (Dong 
et al., 2003) and augment the density and clustering of proteins (i.e., 
neurotransmitter receptors) in postsynaptic membranes (Caruncho et al., 2004). 
These findings further support a role for reelin in the regulation of glutamatergic 
input strength onto dendritic spines (Caruncho et al., 2004).  
 
3.1.2 Reelin in Peripheral Tissues  
 As mentioned, reelin is not only expressed in the brain, but also in 
peripheral tissues, including the kidneys, liver, and blood (Ikeda & Terashima, 
1997; Smallheiser et al., 2000), and in bone barrow (Chu et al., 2014), platelets 
(Tseng et al., 2010), lymphatic vessels (Samama & Boehm, 2005; Lutter et al., 
2012), and the enteric nervous system (Bottner et al., 2014). The peripheral 
activity of reelin is much less understood than its functional roles in brain 
development and plasticity in the central nervous system, but its expression has 
been found to go up sharply following the injury of some organs (Kobold et al., 
2002; Pulido et al., 2007). In blood, reelin is likely secreted into the plasma by 
hepatocytes, platelets and potentially red blood cells. Here, it has been shown to 
play a role in the formation of red bIood cells in bone marrow (Chu et al., 2014). 
Reelin has also been shown to regulate lymphatic vessel formation (Lutter et al., 
2012). In platelets, reelin may be affecting coagulation pattern and inflammatory 
events. Importantly, alterations in reelin plasma levels have been found in 
schizophrenia and mood disorders. Specifically, a significant increase in 410 kDa 
reelin moiety has been observed in schizophrenia (49%), while a non-significant 
increase has been observed in major depression (34%), and in contrast, a non-
significant decrease in bipolar disorder (33%) has been observed. Alternatively, 
the 180 kDa Reelin values have been shown to be significantly decreased in 
depression (49%) and in bipolar disorder (29%), compared with controls (Fatemi 
et al., 2001a).   
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3.2 Implications for Reelin in Major Depressive Disorder 
 3.2.1 Reelin in Patients with Mood and Psychiatric Disorders 
 Several neuropsychiatric disorders, including schizophrenia, bipolar 
disorder, autism, and major depressive disorder have been proposed to share 
characteristic biological risk factors. In this context, altered reelin expression has 
been widely studied for its relevance as one of the factors common to these 
disorders. Disrupted brain expression of reelin has been frequently implicated in 
the pathophysiology of these disorders, including schizophrenia (Fatemi, Kroll, & 
Stary, 2001; Impagnatiello et al., 1998), bipolar disorder (Fatemi, Earle, & 
McMenomy, 2000; Guidotti et al., 2000), autism (Fatemi, 2002), and major 
depression (Lussier et al., 2009, 2011, 2013). In post-mortem brain tissue of 
patients with SZ and BP disorder, reelin expression has been found to be 
reduced by approximately 50% in the PFC, temporal cortex, hippocampus, and 
caudate nucleus (Impagnatiello et al., 1998; Fatemi, Earle, & McMenomy, 2000; 
Guidotti et al., 2000). Similarly, in patients with depression, post-mortem 
analyses show a general decrease in hippocampal reelin expression (Fatemi et 
al., 2000; Knable et al., 2004).  
 
3.2.2 Reelin in Animal Models of Depression 
 Animal models in which reelin expression is genetically decreased can 
elucidate important information regarding the impact of reelin on cognitive 
functioning and its implications for understanding the pathophysiology of 
neuropsychiatric illness. Heterozygous reeler mice (HRM) carry a naturally-
occurring mutation that decreases normal levels of reelin protein by 
approximately 50% in the brain and peripheral tissues. These mice have been 
widely used to study the impact of impaired reelin expression as it relates to the 
biological characteristics underlying behavioral impairments present in mood and 
psychiatric disorders. Although HRM do not exhibit overt differences in 
phenotype (Teuting et al., 2006; Caruncho et al., 2016), they do display 
alterations in some endophenotypes that have relevance to these disorders. For 
instance, HRM mice have been shown to have significantly decreased density of 
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dendritic spines and deficits in LTP expression (Teuting et al., 1999, 2006), as 
well as impaired hippocampal-dependent learning and plasticity (Qiu et al., 
2006). Importantly, administration of recombinant reelin to hippocampal slices 
has been shown to enhance hippocampal LTP (Pujadas et al., 2010; Rogers et 
al., 2011). Other studies have reported deficits in prepulse inhibition (PPI) in 
HRM, which is considered to measure sensorimotor gating and represent an 
endophenotype of psychosis (Barr et al., 2008). In relation to the link between 
stress and depression, adult HRM with impaired reelin signaling appear to be 
more vulnerable to the negative effects of glucocorticoids (Lussier, Romay-
Tallon, Kalynchuk, & Caruncho, 2011; Buret and van den Buuse, 2014; 
Schroeder et al., 2015). Lussier and colleagues (2011) found that in the absence 
of CORT, HRM mice do not display any deficits in depression-like behavior, 
hippocampal neurogenesis, or hippocampal reelin expression. However, in the 
presence of CORT, HRM mice show dose-dependent increases in depression-
like behavior, decreases in neuronal survival and maturation, and decreases in 
hippocampal reelin expression, that were more pronounced than in wild-type 
(WT) mice (Lussier et al., 2011). Similarly, Notoras and colleagues (2017) 
employed an exogenous CORT paradigm in young adult WT and HRM mice 
wherein CORT (50mg/L) was administered in the drinking water for a 3-week 
period. HRM mice were more susceptible to the elevated levels of 
glucocorticoids, displaying increased immobility on the FST as compared to WT 
mice. These results provide evidence that mice with impaired reelin signaling are 
more susceptible to the negative effects of glucocorticoids and this evidence 
supports a role for reelin in the pathophysiology of mood disorders (Fatemi et al., 
2000; Guidotti et al., 2000).   
It is now well-established that increased levels of glucocorticoids can result in 
the downregulation of reelin expression in several brain regions, including the 
hippocampus (Lussier et al., 2009; Fenton et al., 2015). In fact, endogenous 
reelin expression has been proposed as a marker of stress resilience (Fatemi, 
2011) that may also regulate resilience to mood disorders brought on by stress 
induction (Fatemi et al., 2000). Lussier and colleagues (2009) showed that 21 
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days of CORT injections produces decreases in reelin-expressing cells in the 
SGZ (26%), as well as decreases in diffuse reelin expression in the CA1 SLM 
(21%) of the DG. Given that the SGZ is the site where adult hippocampal 
neurogenesis takes place, decreases in reelin-expressing cells in this region is 
particularly relevant regarding a role for reelin in depression and neurogenesis. 
More specifically, reelin-expressing GABAergic interneurons may be affecting the 
degree and rate of hippocampal neurogenesis. Our lab sought to investigate this 
by looking at the parallel time course of hippocampal neurogenesis and reelin 
expression in the SGZ. CORT-induced increases in depression-like behavior 
were accompanied by decreases in the number and dendritic complexity of 
immature dentate granule cells and this was paralleled with decreases in reelin 
expression in the dentate subgranular zone (26%) (Lussier, Lebedeva, Fenton, 
Guskjolen, & Caruncho, 2013a). Furthermore, this effect is dose- and time-
dependent. Specifically, the gradual increase in depression-like behavior and 
decrease in newborn neuron maturation rate was concomitant with a decrease in 
reelin expression that was not observable at 7 days, but showed a 25% decrease 
at 14 days, and a 26% decrease at 21 days (Lussier et al., 2013a). These data 
suggest that the downregulation of reelin disrupts hippocampal neuronal 
maturation, which leads to deleterious behavioral outcomes. Consistent with this 
is the finding that inactivation of the reelin signaling pathway leads to 
impairments in adult neurogenesis (Teixeira et al., 2012).  
Together, these findings evidence a role for reelin in susceptibility and 
adaptation to chronic stress and provide support for the investigation of reelin in 
the context of susceptibility to stress-related mood disorders, such as depression 
and bipolar disorder (Teixeira et al., 2011). This preclinical body of research 
opens up an avenue for exploring the potential benefits of increasing 
endogenous reelin levels in the development of novel therapeutics for depression 
and other mood disorders. Further support for this proposal comes from 
preclinical research demonstrating that several antidepressants increase reelin 
expression in the PFC (Fatemi et al., 2009), and administration of the tricyclic 
antidepressant imipramine in CORT-treated rats, restores rodent hippocampal 
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reelin levels, coincident with a reversal in depression-like behavior (Fenton et al., 
2015). 
In contrast to increased stress susceptibility observed in reelin deficient mice, 
reelin overexpression has been shown to protect against the development of a 
depressive phenotype (Teixeira et al., 2011) and reelin supplementation has 
been shown to enhance synaptic plasticity, dendritic spine density, and cognitive 
ability in wild-type mice (Rogers et al., 2011), as well as restore sensory motor 
gating, synaptic plasticity and associative learning deficits in HRM (Rogers et al., 
2013).  
Given that reelin is downregulated in depression, that chronic stress and 
chronic CORT paradigms in rodents lead to behavioral and neurochemical 
deficits that are concurrent with decreases in reelin expression, and that reelin 
overexpression in animal models has protective effects, our lab was motivated to 
investigate the effects of recombinant reelin administration on CORT-induced 
behavioral and neurobiological deficits. Our findings showed that 
intrahippocampal infusions of reelin restored the behavioral phenotype following 
repeated CORT, as measured by the FST. Furthermore, this behavioral 
restoration was paralleled by a restoration of hippocampal neurogenesis 
(Brymer, unpublished data). While these studies report the behavioral and 
neurochemical effects of reelin infusions in the brain, much less is known about 
the effects of peripheral reelin administration on the brain. However, recent 
findings have reported reelin immunoreactivity in endothelial cells in brain regions 
showing high levels of extracellular reelin expression (Perez-Costas et al., 2015). 
Based on these findings, it is possible that peripherally expressed reelin can 
reach certain areas of the brain in order to affect brain functioning. Furthermore, 
exogenous administration of peripheral reelin may enhance these effects of 
reelin on brain functioning and serve a protective role under conditions of 
compromised functioning.   
 
3.3 Peripheral Reelin: Relation to Stress and Depression  
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3.3.1 Serotonin Transporter (SERT) Membrane Protein Clustering: 
Relation to Depression 
 The plasma membrane is a lipid bilayer that contains many embedded 
proteins that are able to move freely, to a certain extent, within the membrane. 
Within this membrane, there are specific domains wherein proteins interact to 
affect their physiological roles (Rivera-Baltanas et al., 2010). Neurotransmitter 
transporters and receptors are located in both pre- and post-synaptic sites, and 
have been shown to assemble in lipid rafts within the membrane (Ostrom & Insel, 
2004). Lipid rafts are compartmentalized regions of the membrane that have 
important ramifications for the interaction of proteins, such that deviations in the 
clustering of membrane proteins in these regions can contribute to 
pathophysiology (Romay-Tallon et al., 2017).  
In addition to factors that act directly on the brain, there is also evidence to 
implicate interventions that act upon the immune system as promising avenues 
for antidepressant targets. To support this, alterations in membrane protein 
clustering of the serotonin transporter (SERT) and serotonin 2A receptor on the 
plasma membrane of peripheral lymphocytes has been proposed as a novel 
biomarker of depression (Rivera-Baltanas et al., 2012). More specifically, 
patients with depression show a distinct profile of membrane protein clustering 
(MPC) as compared to healthy controls, evidenced by decreased SERT binding 
in lymphocytes as well as an increase in the size of SERT and serotonin 2A 
receptor clusters (Rivera-Baltanas et al., 2012, 2014). Notably, SERT is one of 
the main targets of antidepressant action, and importantly, this altered pattern of 
MPC in depression is reversed in patients that are responsive to antidepressant 
treatment, with alterations of SERT clustering in depression correlating with the 
remittance of anhedonia symptoms (Rivera-Baltanas et al., 2015). This is 
important because anhedonia is a fundamental symptom of depression, and if 
remittance of anhedonic symptoms can be predicted based upon the SERT 
clustering pattern in patients, this could help inform the course of antidepressant 
treatment.  
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Similar to what has been observed in patients with depression, a similar 
pattern of MPC is also altered in both reelin-deficient mice (Rivera-Baltanas et 
al., 2010) and in CORT-treated rats (Fenton et al., 2015b), which will be 
discussed in the following two sections.  
3.3.2 Role of Reelin in Membrane Protein Clustering 
The pattern of MPC in lymphocytes is altered in reelin-deficient mice, 
including both HRM and reeler mice. Specifically, HRM show an increase in both 
the size and number of SERT clusters in lymphocytes, while reeler mice show an 
increase in SERT cluster size that is more pronounced than that in HRM (Rivera-
Baltanas et al., 2010). SERT is primarily responsible for the recapture of 
serotonin from the extracellular space. The clustering of SERT into lipid raft 
membrane domains appears to be critical for serotonin (5-HT) reuptake activity 
and SERT functional roles. A decrease in reelin expression appears to bring 
about the spread of SERT clusters of larger size, impairing its optimal 
functioning. HRM are also more susceptible to the depressiogenic effects of 
CORT, and both HRM and reeler mice show disrupted cytokine secretion from 
lymphocytes and macrophages (Green-Johnson et al., 1995).  
Markers of inflammation hold an important focus in the field of depression 
research, with levels of proinflammatory cytokines considered indicative of 
depressive pathophysiology (see reviews listed in Caruncho et al., 2016). This 
suggests that alterations in serotonin transporter clustering in blood lymphocytes 
associated with a decrease in reelin expression may be having an effect in 
immune system alterations that show comorbidity with depression. Thus, 
decreased reelin expression influences MPC in lymphocytes that may lead to 
disruptions of cytokine release, holding implications for the pathophysiology of 
depression. 
3.3.3 CORT effects on Membrane Protein Clustering 
As just discussed, reelin-deficient mice show altered MPC in immune cells. 
In CORT-treated rats that show depression-like behavior, reductions in DG 
reelin-expressing cells are observed (Lussier et al., 2013), with similar reelin 
reductions seen in depressed patients (Fatemi et al., 2000). This leads to the 
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question of whether CORT treatment alters MPC clustering in lymphocytes in a 
similar fashion to that observed in patients with depression. In fact, rats exhibiting 
a depressive phenotype following 3 weeks of CORT treatment also exhibit a 
significant increase in SERT and 5-HT 2A receptor cluster size in lymphocyte 
membranes, as compared to control rats. Furthermore, the increase in cluster 
size is associated with an increase in depression-like behavior in the FST 
(Fenton et al., 2015b).  
Another interesting finding opens up the possibility for a protective role of 
the adaptive immune system following chronic stress. Lymphocytes extracted 
from mice that previously underwent chronic stress were implanted in naïve 
mice. These implanted lymphocytes went on to produce antidepressant-like 
outcomes. More specifically, the recipient mice showed reduced anxiety, 
increased social behavior, and increased hippocampal cell proliferation 
compared with mice that did not receive donor cells. These recipient mice also 
had reduced levels of proinflammatory cytokine levels in the blood (Brachman et 
al., 2015). These results suggest that chronic stress can induce adaptive 
changes in the immune system, which serve to confer stress resilience.  
Together, these findings implicate the peripheral immune system as an 
important target in the development of antidepressant therapies. Cumulatively, (i) 
the alterations in reelin expression observed in both the CNS and in the 
periphery in MDD and in animal models of depression, (ii) the observations of 
reelin’s facilitative actions on various brain functions, and (iii) the observations of 
behavioral and neurochemical protective effects following reelin supplementation, 
all provide substantial evidence for targeting the reelin system for the purpose of 
novel and efficacious antidepressant development.  
 
 
4. Objectives and Hypotheses 
 
This literature review has described: (i) disrupted HPA axis and various 
alterations in brain structure and function associated with depression, (ii) the 
 37 
 
CORT model as a valid animal model of depression, (iii) reelin alterations in 
depression and in CORT-treated rats, (iv) reversals of the behavioral phenotype 
and restorations of neurogenesis following intra-hippocampal reelin infusions in 
the CORT model, (v) the expression of reelin in blood plasma and peripheral 
tissues where it affects MPC that may relate to the expression of cytokines, and 
(vi) altered pattern of MPC in CORT-treated rats and in (vii) patients with 
depression that is reversed when antidepressant treatment is effective. 
Expanding on this body of research, we asked whether IV peripheral 
administration of reelin can rescue both the behavioral and neurochemical 
phenotype following repeated CORT. In order to investigate the impact of reelin 
on the behavioral phenotype, we measured depression-like behavior following 
either repeated CORT, or repeated CORT with the addition of peripheral reelin 
administration. We also wanted to begin to explore the possible mechanisms 
underlying reelin’s effects by asking whether reelin has direct activity on 
peripheral immune functioning and/or indirect activity on brain regions by 
crossing the blood brain barrier. To do so, we investigated (i) the SERT 
clustering pattern in peripheral lymphocytes as a possible target of reelin’s 
antidepressant action, and (ii) the rate of neuronal maturation in the dentate 
gyrus of the hippocampus, as a secondary target for reelin’s antidepressant 
potential. In order to address the research aims, a rodent model of depression 
utilizing chronic corticosterone treatment was employed.  
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Abstract 
 
Long-term stress exposure significantly contributes to the development of 
depression. In rodents, chronic exposure to corticosterone (CORT) leads to 
reductions in hippocampal neurogenesis and expression of the extracellular 
matrix protein reelin, which facilitates synaptic plasticity, long-term memory, and 
neurogenesis. We previously found that rats administered weekly intra-
hippocampal infusions of reelin (1μl/μg) alongside CORT, displayed a significant 
reduction in depression-like behavior compared to control rats. Reelin has also 
been shown to affect the protein clustering pattern of the 5-HT transporter on 
lymphocyte membranes. Importantly, this clustering pattern is associated with 
depression and responsiveness to treatment. Both patients diagnosed with 
depression, and rats administered repeated CORT, show an increase in the size 
of SERT clusters. The current experiment employed a novel approach to 
determine whether peripheral reelin injections can reverse behavioral 
impairments following prolonged CORT exposure. A secondary aim was to 
explore the peripheral and/or central mechanisms by which reelin injections can 
impact depressive symptomology. Rats received a single daily subcutaneous 
injection of CORT (40 mg/kg) or saline for 21 consecutive days, in conjunction 
with intravenous injection of reelin (3μg/ml or 5µg/ml) or saline, either every 5 or 
10 days. The forced swim test (FST) was used to measure depression-like 
behaviour. CORT- treated rats displayed significantly increased depression-like 
behaviour on the FST compared to control rats. Importantly, this effect was 
reversed with addition of peripheral reelin at all doses administered. CORT-
treated rats had an increase in the size of SERT clusters reminiscent of the 
clustering pattern seen in patients with depression, which was reversed with the 
addition of peripheral reelin. Furthermore, CORT-treated rats showed a decrease 
in the maturation rate of newborn neurons in the hippocampal subgranular zone, 
as compared to control rats. CORT-treated rats administered reelin also showed 
a general decrease in newborn neuron maturation rate. Hence, reelin injections 
did not reverse the CORT-induced reductions in the dendritic complexity of 
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immature granule neurons. This finding suggests that decreases in dendritic 
maturation of newborn hippocampal neurons do not underlie the antidepressant-
like effects of peripheral reelin. Alternatively, findings suggest that reelin 
regulates SERT membrane protein clustering, optimizing its functioning, to 
reverse depressive symptomology.  
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1. INTRODUCTION 
Depression is a both a common and serious psychiatric illness. According to 
the World Health Organization (2017), more than 300 million people worldwide 
are affected by depression. Despite the widespread impact of major depression, 
there remains major challenges in treatment of the disorder. Remission rates 
range from approximately 25-40%, even after at least 2 months of treatment 
(Keller et al., 1998; Trivedi et al., 2006). Furthermore, in a large clinical study of 
outpatients diagnosed with major depressive disorder, patients who did achieve 
response or remission did so only after at least 8 weeks of treatment with an 
SSRI (Trivedi et al., 2006). This finding evidences a substantial therapeutic delay 
in patients undergoing standard treatment with an SSRI. If left inadequately 
treated, depression can lead to suicide, a pandemic that claims approximately 
800, 000 people each year (World Health Organization, 2017). Hence, there is a 
clear need for the development of faster-acting and more effective 
antidepressants.  
Stress is a primary risk factor for the development of depression, with 
prolonged stress posing serious consequences for brain structure and function. 
The hippocampus is a limbic brain structure that is particularly susceptible to the 
negative effects of chronic stress. Hippocampal alterations have been implicated 
in depressive illness. Decreased hippocampal volume has been observed in 
patients with depression (MacQueen et al., 2003; Campbell et al., 2004). The 
development of rodent models of depression employing chronic stress paradigms 
have allowed for observations of hippocampal remodeling coincident with the 
development of depression-like symtoms. Specifically, both chronic stress and 
chronic treatment with corticosterone leads to hippocampal volume loss, atrophy 
of hippocampal pyramidal cell dendrites, loss of CA3 synapses (Magarinos et al., 
1998, 1999; Sousa et al.,1998, 2000; Woolley et al.,1990; Sousa et al., 2000; 
Tata et al., 2006), and reductions in hippocampal neurogenesis (Fuchs and 
Gould, 2000; Pham et al., 2003; Santarelli et al., 2003; Sapolsky, 2004; Lussier 
et al., 2011, 2013), that are reversed following antidepressant treatment (Malberg 
et al., 2000; Scott et al., 2000; van Praag et al., 1999; David et al., 2009).  
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Chronic CORT treatment has also been shown to lead to reduced expression 
of the extracellular matrix protein reelin (Lussier et al., 2009). Reelin plays an 
important role in the hippocampus, where it facilitates synaptic plasticity, long-
term potentiation, (D’Arcangelo, 2005; Weeber et al., 2002; Rogers et al., 2013), 
synaptogenesis, dendritic spine growth and density (Costa et al., 2002; Niu et al., 
2008; Chameau et al., 2009), and hippocampal neurogenesis (Pujadas et al., 
2010). CORT-induced reductions in hippocampal reelin expression and neuronal 
maturation rate have been shown to coincide with the development of 
depression-like behavior in rodents (Lussier et al., 2013). Moreover, direct 
infusion of reelin into the hippocampus fully restores these behavioral and 
neurochemical parameters following CORT exposure (Brymer et al., in 
preparation).  
Mice that are deficient in reelin are more susceptible to the depressogenic 
effects of CORT on behavior, reelin expression, and rate of newborn neuron 
maturation (Lussier et al., 2011). Reelin-deficient mice also show changes in the 
pattern of membrane protein clustering of the serotonin transporter in 
lymphocytes, displaying an increase in the size of SERT clusters on lymphocyte 
membranes (Rivera-Baltanas et al., 2010). Similarly, CORT-treated rats also 
show a significant increase in SERT cluster size along lymphocyte membranes, 
as compared to control rats, and increased cluster size is positively correlated 
with increased depression-like behavior in the FST (Fenton et al., 2015b). 
Importantly, patients with depression also show a similar increase in the size of 
SERT clusters along lymphocyte membranes (Rivera-Baltanas et al., 2012, 
2014). SERT is one of the main targets of antidepressant action, and holds 
important implications for antidepressant efficacy. 
To summarize, reelin holds neuroprotective roles in the hippocampus and is 
also associated with SERT MPC in peripheral lymphocytes, - the pattern of which 
is altered in depression. As reelin is also expressed peripherally, we were 
motivated to examine whether injecting reelin into the bloodstream could bring 
about antidepressant outcomes, by way of direct brain interactions or through the 
regulation of SERT MPC in lymphocytes.  
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2. MATERIALS AND METHODS 
2.1 Animals 
We used 84 male Long-Evans rats (Charles River Laboratories; Montreal, 
Quebec, Canada), weighing 200-250g upon arrival, in the study. Rats were 
housed individually in clear plastic cages with free access to food and water. The 
thermally-controlled colony room was maintained at a 12/12 hr light/dark cycle. 
All procedures were approved by the University of Saskatchewan Animal 
Research Ethics Board, and conducted in accordance with the Canadian Council 
on Animal Care. 
 
2.2 Experimental Design  
2.2.1 Handling and Experimental Conditions 
Upon arrival to the facility, rats were allowed 48 hours to habituate to the 
colony room. Following this, all rats underwent a 7-day handling period that 
incorporated a habituation period with the restraint device that would be used 
during the tail vein injection procedure. On days 1-3, rats were simply handled in 
order to habituate them to the experimenter. On day 4, rats were introduced to 
the restraint device, which was placed in the cage for a period of one minute, 
while they were allowed to explore. On days 5, 6, and 7 rats were placed in the 
restraint device for a period of one minute to initiate habituation to the device. 
Following the handling period, rats were then weight-matched and assigned to 
one of two experimental conditions based on the subcutaneous administration of 
21 days of: (i) saline or (ii) CORT (40mg/kg). 
 Rats were then subdivided into 12 groups, according to (ii) intravenous 
saline (every 5 or 10 days) or reelin at four varying doses of reelin (3 µg/ml every 
10 days; 3 µg/ml every 5 days; 5 µg/ml every 10 days; 5 µg/ml every 5 days). 
This resulted in 12 experimental conditions, as illustrated below:  
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Table 1. Illustration of the twelve experimental subgroups. 
 
 Dose Frequency SC Vehicle SC CORT 
IV Vehicle  
 
 
N/A 
Every 10 days N=6 N=6 
Every 5 days N=6 N=6 
IV Reelin 
 
3µg/ml Every 10 days N=6 N=6 
Every 5 days N=8 N=8 
5µg/ml Every 10 days N=8 N=8 
Every 5 days N=8 N=8 
 
2.2.2 CORT Injection Paradigm   
All CORT and vehicle injections were administered subcutaneously once 
per day (between 9:00 and 11:00 am). CORT (Steraloids, Newport, RI, USA) was 
suspended in 0.9% (w/v) physiological saline with 2% (v/v) Polysorbate-80 
(Sigma-Aldrich) solution and given at a dose of 40 mg/kg in a volume of 1 ml/kg. 
Our lab has reported that the 40mg/kg dose reliably increases depression-like 
behavior in rats (Johnson et al., 2006; Lussier et al., 2013, Fenton et al., 2015). 
The body weight of each rat was recorded daily from days 1-21 of CORT/vehicle 
treatment. 
 
2.2.3 Reelin Injection Paradigm 
Recombinant reelin (3820-MR-025/CR; R & D Systems, Minneapolis, MN, 
USA) was reconstituted immediately prior to injections to a working concentration 
of 3ug/ml or 5ug/ml in 0.1 M PBS (pH = 7.4). Reelin injections were conducted in 
a different room from those used for CORT injections and housing. Rats were 
placed in a plastic restrainer and their tail was sanitized and warmed in a beaker 
of warm water in order to dilate the blood vessels prior to injection. A catheter 
was then inserted into the lateral tail vein using a 25G needle. The needle was 
then withdrawn and a syringe was attached to the catheter for blood withdrawal. 
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Once the appropriate amount of blood was obtained, the syringe was removed 
and a second syringe containing reconstituted reelin (3ug/ml or 5ug/ml) or saline 
was attached to the catheter and the appropriate solution was administered at a 
rate of 0.5 ml over a 30-second period. Both the catheter and the syringe were 
then withdrawn simultaneously from the vein and a cotton swab was applied to 
the area and held there until bleeding stopped. The rat was then removed from 
the restrainer and placed back in its home cage. Figure 3 below illustrates the 
schedule for the reelin and CORT injections. 
 
 
 
 
 
 
Figure 3. Schematic of experiment timeline, representing the schedule for Vehicle/CORT 
subcutaneous injections and Vehicle/Reelin intravenous injections.  
 
2.3 Behavioural Testing 
Behavioural testing was conducted in a different room from the rooms used 
for housing, CORT injections, and reelin injections. All rats underwent behavioral 
testing between 8 am and 5 pm. Behaviour was videotaped and scored at a later 
time point. The forced swim test was used to assess depression-like behavior 
and the open field test was used to assess motoric and anxiety-like behaviors. 
2.3.1 Forced Swim Test 
The FST was conducted on the day after the final injection (Day 22). A 
modified version of the Porsolt test (1977,1978), employing a single immersion 
trial was used, as described previously (Gregus et al., 2005). Briefly, each rat 
was placed individually into a Plexiglas swim tank (25 cm wide X 25 cm long X 
Week 1 
Handling 
Day 1 Day 6 Day 21Day 16 Day 11 Day 22 Day 23
FST 
Perfusions 
P 
OFT
Vehicle or CORT injections 
P 
Reelin/Vehicle injections every 5 days 
 
Reelin/Vehicle injections every 10 days 
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60 cm high, 27 ± 2 °C water, 30 cm deep) for 10 minutes. The duration of time 
each rat spent immobile, and the duration of time spent swimming during the 10-
minute test was measured (Cryan et al., 2005). Immobility was defined as the 
absence of head movement or body propulsion (Strekalova et al., 2004; Cryan et 
al., 2005; Stevenson et al., 2009), and swimming was defined as the directed 
movement of the animal’s head and body. The water in the container was 
changed after each rat. More time spent immobile and less time actively 
swimming or struggling reflects learned helplessness in response to a 
threat/challenge and is considered to be indicative of a depressive phenotype. 
Behavior was scored for separately by two different experimenters, each blind to 
the treatment group the rat belonged to, in order to ascertain inter-rater reliability.  
2.3.2 Open Field Test 
The open field test was conducted on the day after the forced swim test, 
and prior to perfusions. Each rat was placed individually into the center of a 50 
cm X 50 cm plastic box, which was divided into 16 equal squares. The rat was 
left in the box for a period of 5 minutes. The inner 4 squares were defined as the 
center and the outer 12 squares were defined as the periphery. Two behavioral 
measures were quantified for each rat: the amount of time spent in the center of 
the arena (in sec), and the total distance traveled (in cm) during the 5-minute test 
period. The total distance traveled by the rat reflects locomotive behaviour and 
this was measured in order to ensure that a restoration of immobility deficits with 
peripheral reelin could not be attributed to a general motoric effect of reelin. The 
amount of time spent in the center of the arena was measured in order to assess 
a potential effect of either CORT or reelin on anxiety-like behavior. This measure 
depends on rats’ spontaneous exploration of an open field. Rats will naturally 
seek protection near the peripheral edges of an open field under conditions of 
increased anxiety. Hence, greater anxiety-like behavior is reflected by a lesser 
amount of time spent in the center of the arena. All behaviors were coded using 
Ethovision software (version 3.0; Wageningen, The Netherlands). 
 
2.4 Blood Work Procedures 
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Immediately prior to each reelin injection, 0.3 – 0.5 ml of blood was 
obtained from each rat using a catheter inserted into the lateral tail vein. 2-3 
drops of blood from each sample were placed on Super-Frost Plus slides and 
then gently smeared in a unidirectional manner across the slide using a 
coverslip. This procedure effectively created a thin blood smear on each slide for 
subsequent analysis. Three thin smears were obtained for each rat on each day 
of blood extraction. They were dried at room temperature for at least 1 hr., and 
then stored at - 80 °C until used for immunocytochemistry. On the final day of the 
experiment, rats were euthanized and sacrificed. Blood was drawn via heart 
puncture (up to 3ml in total) immediately prior to perfusions. In addition to 3 thin 
smears, blood was collected in 5 ml Eppendorf tubes containing ADC solution in 
a 1:7 proportion before being appropriately stored.  
2.4.1 Immunocytochemistry of SERT in blood smears 
Immunocytochemistry was conducted directly on smears according to a 
previously described procedure (Romay-Tallon et al., 2017). The first step was a 
fixation step. The frozen smears were brought back to room temperature and 
allowed to dry. They were then fixed with 0.5 ml of 1% PFA for 5 min at room 
temperature. The smears were comprised of a whole blood sample made up of 
red blood cells, platelets and white blood cells, but for the purposes of the current 
experiment, only the lymphocytes were of interest. In order to avoid unspecific 
labelling in the whole blood sample, a pre-incubation step was performed for 1 h 
at room temperature with 10% rat IgG diluted in 1% BSA and PBS. For labeling 
of SERT, a polyclonal primary antibody raised in rabbit was used that specifically 
recognizes epitopes of both human and rat SERT [anti-serotonin transporter: 
AB10514P (Millipore, Billerica, Massachusetts)]. Smears were incubated with the 
primary antibody overnight, diluted 1:250 in 1% BSA and PBS. After incubating, 
smears were rinsed with PBS 3 times, 10 min each time. The samples were then 
incubated with a 1:200 solution of fluorescent secondary antibody [Alexa Fluor 
568, goat anti-rabbit: (A-11008, Molecular Probes, Eugene, Oregon)] in 1% BSA 
in PBS for 2 hrs at room temperature. This step is light sensitive, and therefore, it 
was carried out in the dark. The excess antibody was then rinsed off by washing 
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the samples with PBS 3 times for 10 min each. To facilitate the identification of 
the lymphocytes, a nuclear marker was used [Hoechst 33,258 (Invitrogen, 
Molecular Probes, Carlsbad, California), which was applied at 2 μg/ml for 15 min 
at room temperature]. After nuclear labeling, the smears were rinsed with PBS 
for 10 min, left to dry, and coverslipped. The slides were then stored in the 
freezer at -20 °C. 
 
2.5 Perfusions and Tissue Preparation 
On day 22, rats were anesthetized with isofluorane and perfused 
transcardially with 0.9% sodium chloride solution and 4% (w/v) paraformaldehyde 
in 0.1 M phosphate buffer (PB, pH 7.4). The brains were dissected keeping the 
cerebellum and olfactory bulb intact. Tissue was postfixed in 4% (w/v) 
paraformaldehyde for 48 hours at 4 °C, and then they were placed in a .1 M 
phosphate buffered saline (PBS) and sodium azide solution at 4 °C until 
sectioning. Brains were sectioned at 30 um using a cryostat. Brain sections were 
stored in cryoprotectant solution at – 20 °C until used for immunohistochemistry.  
 
2.6 Image processing and quantification of SERT clusters 
SERT membrane protein clustering was analyzed in smears from blood 
samples obtained on the day of perfusions. SERT immunolabelling is evidenced 
as immunofluorescent clusters observed primarily in the lymphocyte plasma 
membrane. Pictures were acquired at 100× magnification from 100 individual 
lymphocytes per rat using a fluorescence microscope. The pictures were 
subsequently analyzed using ImageJ software (1.48v, NIH, USA). ImageJ 
performs measurements in pixels, so the program must be calibrated to reflect 
the real values of the obtained measurements (i.e., number and size of the SERT 
clusters). Hence, a known distance is entered into the program to establish 
equivalency between pixels and distance given in um. Additionally, background 
conditions were adjusted to optimize the analysis of clusters. To do this, the size 
of the smallest particle which was not considered background was indicated. 
Finally, a step to remove outliers was also performed, in order to delete small 
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specks that might interfere with the analysis and give an overestimation of cluster 
number and an underestimation of cluster size (Romay-Tallon et al., 2017). At 
this point, the program creates a binary image for easy quantification of cluster 
number and size. The minimum size of particle for the program to analyze was 
indicated as 0.05, and the maximum size was set at ‘infinite’, to provide an 
accurate measure of the clusters. Once the set of conditions for analysis using 
ImageJ was established, they were kept constant, so that results could be 
compared accurately across all conditions. SERT+ immunolabeling was analyzed 
throughout the entire thickness of the sample (~10µm). As discussed, two sets of 
measurements were obtained from each lymphocyte: the size of SERT-
expressing clusters, and the number of SERT-expressing clusters. For each 
sample, the measurements from each lymphocyte were averaged. 
 
2.7 Doublecortin (DCX) Immunohistochemistry 
Every sixth section was used for immunostaining and 2 sections were 
quantified per animal. Immunohistochemistry was performed on free-floating 
sections, as follows: The sections were washed in TBS and incubated in sodium 
citrate (pH 6.0; 85 °C) for 30 minutes. After 3 TBS washes, the sections were 
incubated for 24 hours at room temperature with rabbit anti-DCX primary 
antibody (Cell Signaling, Danvers, MA) at 1:1000 diluted in a solution containing 
Triton X-100 (.5%, v/v), normal goat serum (NGS; 5%; v/v), and BSA (1%; w/v) 
dissolved in TBS. After incubation in the primary antibody, the sections were 
washed in TBS then incubated in 10% (v/v) H2O2 in TBS for 30 min to block 
endogenous peroxidase activity. Sections were then washed in TBS and then 
incubated with biotinylated goat anti-rabbit IgG (1:500, SigmaeAldrich, St. Louis, 
MO) secondary antibody diluted in .5% (v/v) Triton X-100, 5% (v/v) NGS, and 1% 
(w/v) BSA in PBS for 1 hour at room temperature. This was followed by 
incubation in an avidin-biotin complex (1:500, Vecta Stain Elite ABC reagent, 
Vector Labs) for 1 h at room temperature. After washes in TBS and 2 washes in 
.175 M sodium acetate, the sections were stained using .025% DAB and 4.167% 
NiSO4 dissolved in .002% H2O2 and .175M sodium acetate. The reaction was 
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stopped using .175 M sodium acetate as a rinse. The sections were then 
mounted onto slides and left to dry overnight and the coverslipped using Entellan 
resin solution.  
2.7.1 Analyses of DCX Immunolabelling 
To semi-quantify the dendritic morphology of immature granule cells, 
dendritic branching in a subset of DCX+ cells from the SGZ and granule cell layer 
of the DG (from -2.40 mm to approximately -3.94 mm from bregma) was 
categorized in each rat according to the method of Plumpe et al. (2006) and as 
previously described (Lussier et al., 2011; Plumpe et al., 2006). One hundred 
cells per animal were randomly selected using a meander scan method. Each 
cell was assigned to one of six categories based on the presence and extent of 
its apical dendrites. Briefly, categories 1 and 2 represented the proliferative stage 
of development and cells placed into these categories had either no processes 
(category 1) or one short process (category 2). Categories 3 and 4 represented 
an intermediate stage of cell development. Category 3 cells showed a medium 
process that reached the granular cell layer but did not extend into the molecular 
layer. Category 4 cells were similar except that they had a process that reached 
the molecular layer. Categories 5 and 6 represented more mature stages of cell 
development. Category 5 cells had at least one major dendrite branching within 
the molecular layer. Category 6 cells had a defined dendritic tree with delicate 
branching within the granule cell layer. The percentage of cells falling into each 
of these categories was calculated for each animal. 
 
2.8 Statistical Analysis 
All statistical analyses were performed using Statistical Package for the 
Social Sciences (SPSS v 20, Chicago, IL). Separate one-way ANOVAs were 
used to assess the statistical significance of group differences on each measure 
(i.e., body weight, FST behavior, OFT behavior, size and number of SERT 
clusters, and % of DCX+ cells). Significant main effects were followed by Tukey’s 
post-hoc tests where appropriate. The criterion for statistical significance was p < 
0.05. Error bars on all graphs represent the standard error of the mean (SEM).  
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3. RESULTS 
3.1 Body Weight 
Differences in weight gain were analyzed between 4 experimental groups, 
collapsed across dosage of intravenous reelin/saline administered (i.e., Vehicle-
Vehicle, CORT-Vehicle, Vehicle Reelin, CORT-Reelin) by conducting separate 
one-way ANOVAs with experimental group as the independent variable and 
weight (grams) at four weekly time-points as the dependent variable. Consistent 
with past research utilizing an exogenous CORT paradigm (Lussier et al., 2009; 
Lussier et al., 2011; Lussier et al., 2013), CORT had significant effects on body 
weight, with a decrease in weight gain observed with repeated CORT. Significant 
body weight differences were found among the groups on days 1, 7, 14, and 21. 
There was a significant main effect of experimental group on day 1 of injections, 
F(3, 80) = 25.07, p < 0.001. A post-hoc Tukey test revealed that on day 1, 
CORT-Vehicle and CORT-Reelin rats weighed significantly more than Vehicle-
Vehicle and Vehicle-Reelin rats, ps < 0.001 (see Fig 4). The reason for this 
difference was the intentional assignment of heavier rats into CORT treatment 
groups at the outset of the experiment, given the anticipated weight gain 
reduction in these rats. On day 7, a significant main effect of group on body 
weight was observed, F(3, 80) = 11.34, p < 0.001. Post-hoc Tukey analyses 
revealed that the CORT-Reelin rats weighed significantly less than the Vehicle-
Vehicle and Vehicle-Reelin rats, ps < 0.001 (see Fig 4). Again, on day 14 of 
CORT injections, a significant main effect of group on body weight was observed, 
F(3, 80) = 36.41, p < 0.001. A post hoc Tukey test revealed that both the CORT-
Vehicle and CORT-Reelin groups weighed significantly less than both the 
Vehicle-Vehicle and Vehicle-Reelin groups, ps < 0.001 (see Fig 4). Finally, a 
significant main effect of group was observed on day 21, F(3, 80) = 47.98, p < 
0.001. Post-hoc Tukey analyses revealed that both the CORT-Vehicle and 
CORT-Reelin groups weighed significantly less, as compared to both the 
Vehicle-Vehicle and Vehicle-Reelin groups, ps < 0.001 (see Fig 4).  
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Differences in weight gain between the four experimental groups were 
additionally analyzed using a Mixed-design ANOVA, with treatment group (i.e., 
Vehicle-Vehicle, CORT-Vehicle, Vehicle Reelin, CORT-Reelin) as the between-
subjects factor and time as the within-subjects factor. On the Mixed-design 
ANOVA, spehericity could not be assumed, according to Mauchly’s Test of 
Sphericity (p < 0.001), therefore Greenhouse-Geisser correction was employed. 
There was a significant main effect of time on body weight when averaged 
across groups, F(1.42, 113.66) = 141.86, p < 0.001. Additionally, there was a 
significant main effect of treatment on body weight when averaged across time, 
F(3, 80) = 15.19, p < 0.001. Importantly, however, there was a significant 
interaction effect of treatment group X time, F(4.26, 113.66) = 132.65, p < 0.001. 
Following up, Bonferroni pairwise comparisons looking at the effect of each time-
point in all treatment groups, revealed the same significant differences between 
groups for each of the weekly time points, as is reported from the results of the 
independent one-way ANOVAs above.  
Bonferonni pairwise comparisons looking at the effect of all time-points within 
each treatment group revealed that both Vehicle-Vehicle rats and Vehicle-Reelin 
rats differed significantly in their weights between all times points (ps < 0.01), 
showing a steady increase in weight over time. For CORT-Vehicle rats, their 
weight was significantly lower on days 7, 14, and 21, as compared to their weight 
on day 1, ps < 0.002. CORT-Vehicle rats did show a significant increase in 
weight on day 21 as compared to day 14, p < 0.001. Similar to CORT-Vehicle 
rats, CORT-Reelin rats weighed significantly less on days 7, 14, and 21, as 
compared to day 1, ps < 0.001. CORT-Reelin rats weighed significantly more on 
day 21, as compared to day 7 and day 14.  
In sum, the results of both the Mixed-analysis ANOVA and the independent 
one-way ANOVAs evidence that CORT-treated rats had significantly attenuated 
weight gain as compared to Vehicle-treated rats over the course of the 21-day 
injection period.  
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Figure 4. Body weight measured over 21-day injection period. Data is presented as mean 
±SEM. Asterisks represent significantly different groups. 
 
3.2 Forced Swim Test  
As discussed, previous research has shown that rats treated with CORT 
display increased behavior symptomatic of depression on the FST (i.e., 
increased time spent immobile; decreased time spent actively swimming or 
struggling). In the current experiment, a one-way ANOVA was conducted 
separately for each behavior on the FST, with experimental group as the 
independent variable, and immobility and swimming behaviors as the dependent 
variables. First, it should be noted that an independent samples t-test showed 
that Vehicle- and CORT-treated rats that received IV saline every 10 days versus 
IV saline every 5 days did not differ significantly from each other in their 
depression-like behavior in the FST (i.e., immobility and swimming times) or in 
their behavior in the open field test. Therefore, these rats were treated in a 
uniform manner, resulting in Vehicle-Vehicle (N = 12) and CORT-Vehicle (N = 
12) groups.  
Now, results are reported for immobility behavior when collapsed across dose. 
A one-way ANOVA showed a significant main effect of CORT on immobility 
behavior, F(3, 80) = 14.93, p < 0.001 (see Fig 5). As expected, post-hoc Tukey 
tests revealed that the CORT-Vehicle rats spent significantly more time immobile 
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as compared to the Vehicle-Vehicle and Vehicle-Reelin groups, ps < 0.001 (see 
Fig 5). Importantly, the CORT-Vehicle rats also spent significantly more time 
immobile as compared to the CORT-Reelin rats, p = 0.002 (see Fig 5). Post-hoc 
testing also revealed that the CORT-Reelin rats spent significantly more time 
immobile as compared to the Vehicle-Reelin group, p = 0.006 (see Fig 5). Hence, 
the CORT-Reelin rats did not statistically differ from the Vehicle-Vehicle rats and 
showed a decrease in immobility with respect to the CORT-Vehicle rats, but still 
spent more time immobile than the Vehicle-Reelin rats, demonstrating an almost 
complete behavioral reversal on the immobility measure of the FST.  
Next, results are reported for swimming behavior when collapsed across dose. 
Again, a significant main effect of experimental group was found on swimming 
behavior, F(3, 80) = 5.01, p = 0.003 (see Fig 5). As expected, post-hoc Tukey 
tests showed that the CORT-Vehicle rats spent significantly less time actively 
swimming than the Vehicle-Vehicle rats (p = 0.012) and the Vehicle-Reelin rats 
(p = 0.038) (see Fig 5). Importantly, the CORT-Vehicle rats also spent 
significantly less time actively swimming than the CORT rats treated with reelin, p 
= 0.002 (see Fig 5). The CORT-Reelin rats did not significantly differ from the 
vehicle groups in swimming behavior. Hence, a reversal in swimming behavior is 
observed with the addition of recombinant reelin.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. (A) Immobility Time and (B) Swimming Time in the FST. Data is presented as 
mean ±SEM. Lines represent significantly different groups. 
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Results are now reported for immobility behavior according to the dose of 
reelin administered. At the 3µg every 10 day dosage, there was a significant 
main effect of group on immobility behaviour, F(3, 32) = 11.04, p < 0.001 (see Fig 
5.1). Post-hoc Tukey testing showed that the CORT-Vehicle group spent 
significantly more time immobile compared to the Vehicle-Vehicle and Vehicle-
Reelin groups, ps < 0.002 (see Fig 5.1). Additionally, the CORT-Vehicle group 
spent significantly less time immobile compared to the CORT-Reelin group, p = 
0.020 (see Fig 5.1).  
Similarly, at the 3µg every 5 day dosage, there was also a significant main 
effect of group on time spent immobile, F(3, 36) = 11.36, p < 0.001 (see Fig 5.1). 
Post-hoc tests showed that the CORT-Vehicle group spent significantly more 
time immobile than all other groups, p’s < 0.03 (see Fig 5.1).  
At the 5µg every 10 day dosage, there was again a significant main effect of 
group on immobility, F(3, 36) = 11.91, p < 0.001 (see Fig 5.1). Post-hoc Tukey 
tests showed that the CORT-Vehicle rats spent significantly more time immobile 
than both the Vehicle-Vehicle and Vehicle-Reelin groups, ps < 0.001 (see Fig 
5.1).  
Finally, at the 5µg every 5 day dosage, there was a significant main effect of 
group on time spent immobile, F(3, 36) = 12.81, p < 0.001 (see Fig 5.1). The 
CORT-Vehicle group spent significantly more time immobile compared to all 
other groups, ps < 0.02 (see Fig 5.1). Hence, it is important to note that for each 
dose given, there was a significant effect of CORT, and this is consistently 
rescued by peripheral reelin administration. Significantly, this effect holds up for 
the lowest dose of reelin given.  
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Fig 5.1 Immobility Time in the FST for each dosage administered. (A) 3µg/ml every 10 
days. (B) 3µg/ml every 5 days. (C) 5µg/ml every 10 days. (D) 5µg/ml every 5 days. Data is 
presented as mean ±SEM. Lines represent significantly different groups. 
 
Results are now reported for swimming behavior according to the dosage of 
reelin administered. At the lowest dose given, 3µg every 10 days, there was a 
significant main effect of group on swimming behavior, F(3, 32) = 3.26, p = 0.034 
(see Fig 5.2). A Tukey test revealed that the CORT-Vehicle rats spent 
significantly less time swimming than the Vehicle-Vehicle rats, p = 0.019 (see Fig 
5.2). No other significant differences between groups were observed for this 
dosage.  
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At the 3µg every 5 day dosage, there was a significant main effect of group on 
swimming time, F(3, 36) = 3.85, p = 0.017 (see Fig 5.2). The CORT-Vehicle 
group spent significantly less time swimming than the Vehicle-Vehicle group, p = 
0.044, and the CORT-Reelin group, p = 0.024 (see Fig 5.2). No other significant 
differences between groups were found for this dosage.  
At 5µg every 10 days, a significant main effect of group was found, F(3, 36) = 
3.93, p = 0.016 (see Fig 5.2). The CORT-Vehicle group spent significantly less 
time actively swimming than the Vehicle-Vehicle group, p = 0.024, and the 
CORT-Reelin group, p = 0.042 (see Fig 5.2). No other significant differences 
between groups were present.  
Finally, at 5µg every 5 days, a significant main effect of group on time spent 
swimming was observed, F(3, 36) = 3.63, p = 0.022 (see Fig 5.2). A Tukey test 
showed that the CORT-Vehicle rats spent significantly less time swimming than 
the Vehicle-Vehicle rats, p = 0.030, and showed a trend in this direction when 
compared to the CORT-Reelin rats, p = 0.053 (see Fig 5.2). No other significant 
differences between groups were observed at this dose.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 58 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.2 Swimming Time in the FST for each dosage administered. (A) 3µg/ml every 10 
days. (B) 3µg/ml every 5 days. (C) 5µg/ml every 10 days. (D) 5µg/ml every 5 days. Data is 
presented as mean ±SEM. Lines represent significantly different groups. 
 
While it is apparent that the pattern of restoration of behavior for the varying 
doses is less consistent for swimming behavior than for immobility behavior, the 
CORT-Reelin group does not significantly differ from vehicle groups on this 
measure and generally spends more time actively swimming than the CORT-
Vehicle group. Taken together, the current results support that peripheral reelin 
administration effectively reversed the depressive phenotype that was brought 
about by repeated CORT treatment.  
 
3.3 Open Field Test 
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A one-way ANOVA was conducted separately for each behavior on the 
OFT, with experimental group as the independent variable and total distance 
travelled (cm) and duration spent in center of arena (s) as the dependent 
variables. When collapsed across dose, there was no significant main effect of 
treatment group on the total distance travelled (cm) during the 5 minute test 
period, F(3, 78) = 0.53, ns (see Fig 6). Similarly, when collapsed across dose, 
there was no significant main effect of experimental group on the duration of time 
spent in the inner zone of the arena (s) in the 5 minute test period, F(3, 78) = 
2.50, p = 0.07 (see Fig 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6. (A) Distance travelled and (B) Time spent in center zone of arena in OFT. Data is 
presented as mean ±SEM.  
 
When analyzed according to the dose of reelin administered, there were no 
significant main effects of group for any of the doses administered. Specifically, 
at the lowest dose of 3ug every 10 days, there was no significant main effect of 
group on total distance traveled (cm), F(3, 20) = 0.95, ns, nor on duration spent 
in the center of the arena (s), F(3, 20) = 1.38, p = 0.278 (see Fig 6.1). At the 3µg 
every 5 day dose, there was no significant main effect of group on total distance 
traveled, F(3, 22) = 0.37, ns, nor on duration of time spent in center of arena, F(3, 
22) = 0.50, ns (see Fig 6.1). Again, at the 5µg every 10 day dose, there was no 
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significant main effect of group on distance traveled, F(3, 24) = 0.37, ns, nor on 
duration of time spent in the center of arena, F(3, 24) = 0.85, ns (see Fig 6.1). 
Finally, at the highest dose given, 5µg every 5 days, there was no significant 
main effect of experimental group on total distance traveled, F(3, 23) = 1.18, p = 
0.34, nor on duration of time spent in center of arena, F(3, 23) = 2.69, p = 0.07 
(see Fig 6.1). Hence, neither CORT nor reelin produced an effect on locomotive 
or anxiety-like behavior, as measured by the OFT. It may therefore be reasoned 
that the significant behavioral differences observed between experimental groups 
in the FST are reflective of differences in depression-like behavior, rather than 
those of locomotive or anxiety-like behavior.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6.1 Distance travelled and time spent in inner zone of arena in OFT for each dosage 
administered. (A) 3µg/ml every 10 days. (B) 3µg/ml every 5 days. (C) 5µg/ml every 10 days. (D) 
5µg/ml every 5 days. Data is presented as mean ±SEM.  
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3.4 Effects of CORT and Reelin on Membrane Protein Clustering in Lymphocytes 
Thus far, the behavioral findings show that the addition of peripheral reelin 
rescues depression-like behavior, without producing any alterations in OFT 
behavior. In addition to these behavioral parameters, biochemical parameters 
were also measured; specifically, the size (µm2) and number of SERT clusters 
on lymphocyte plasma membranes from rat blood smears were analyzed.  Figure 
7 shows an example of the SERT clustering quantification for each treatment 
group (i.e., V/V, V/R, C/V, C/R). In each group, you can see the original 
microscope image of the sample (~10µm thickness), followed by a conversion of 
the image to a binary colour with subtraction of background, and finally, the 
automatic analyzation of the binary image by ImageJ to quantify the number of 
SERT clusters per lymphocyte and the average size of clusters (see Fig. 7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7. Example of analysis of SERT protein clusters in one lymphocyte from rat blood 
smears, showing the microscope image of SERT immunostaining, the binary image 
obtained in ImageJ, and the actual counts of the number and size of clusters as performed 
by the image analysis system (Romay-Tallon et al., in production). (A) Vehicle-Vehicle (B) 
Vehicle-Reelin (C) CORT-Vehicle (D) CORT-Reelin. 
C/V 
C/R V/R 
V/V 
C 
D B 
A 
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A one-way ANOVA was conducted separately for both the size (µm2) and 
number of SERT clusters, with experimental group as the independent variable, 
and size and number of clusters as the dependent variables. Results are first 
reported for SERT cluster size (µm2) when collapsed across dose of reelin 
administered. A one-way ANOVA showed a significant main effect of CORT on 
the size of SERT clusters, F(3, 91) = 14.87, p < 0.001 (see Fig 8). Post-hoc 
Tukey tests revealed that, as suspected, CORT treatment increased the size of 
SERT clusters, such that the CORT-Vehicle rats exhibited significantly larger 
clusters as compared to the Vehicle-Vehicle and Vehicle-Reelin rats, ps <0.001. 
Importantly, the CORT-Vehicle rats also showed significantly larger clusters as 
compared to the CORT-Reelin rats, p < 0.001 (see Fig 8). Hence, the effect of 
CORT treatment on the size of SERT clusters was significantly rescued with 
addition of peripheral reelin. In regard to the number of SERT clusters, no 
significant main effect of CORT treatment was observed between groups when 
collapsed across dose (see Fig 8).  
 
Fig 8. (A) Size (µm2) of SERT clusters and (B) Number of SERT clusters in lymphocyte 
membranes. Data is presented as mean ±SEM. Lines represent significantly different 
groups.  
  
Next, the size of SERT clusters was analyzed according to the dose of reelin 
administered. At the lowest dose of reelin given, 3µg every 10 days, there was a 
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significant main effect of treatment on the size of SERT clusters, F(3, 45) = 
15.23, p < 0.001 (see Fig 8.1). Post-hoc Tukey testing revealed that the CORT-
Vehicle group showed significantly larger clusters as compared to the Vehicle-
Vehicle, Vehicle-Reelin, and CORT-Reelin groups, ps < 0.002 (see Fig 8.1). 
When reelin was administered at a dose of 3µg every 5 days, a significant main 
effect of treatment was again observed on the size of SERT clusters, F(3, 49) = 
12.66, p < 0.001. A post-hoc Tukey test showed that the CORT-Vehicle rats had 
significantly larger clusters as compared to the Vehicle-Vehicle, Vehicle-Reelin, 
and CORT-Reelin rats, ps < 0.002 (see Fig 8.1). At the 5µg every 10 day 
dosage, a significant main effect of treatment was again observed on the 
clustering size of SERT, F(3, 49) = 21.12, p < 0.001 (see Fig 8.1). A post-hoc 
Tukey test showed that the CORT-Vehicle group had significantly increased 
cluster size compared to the three other groups, ps < 0.004 (see Fig 8.1). Finally, 
when 5µg of reelin was administered every 5 days, there was a significant main 
effect of treatment on the size of SERT clusters, F(3, 49) = 13.00, p < 0.001 (see 
Fig 8.1). Post-hoc Tukey comparisons showed that, just as the case for all other 
doses, the CORT-Vehicle rats had a significantly larger clusters compared to the 
Vehicle-Vehicle, Vehicle-Reelin, and CORT-Reelin rats, ps < 0.03 (see Fig 8.1).  
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Fig 8.1. Size (µm2) of SERT clusters in lymphocyte membranes according to each 
dosage of reelin administered. (A) 3µg/ml every 10 days. (B) 3µg/ml every 5 days. (C) 
5µg/ml every 10 days. (D) 5µg/ml every 5 days. Data is presented as mean ±SEM. Lines 
represent significantly different groups.  
 
Next, the number of SERT clusters was analyzed according to the dose of 
reelin administered. At the lowest dose of reelin, 3µg, administered every 10 
days, no significant main effect of treatment group on the number of clusters was 
found, F(3, 45) = 2.18, p = 0.10 (see Fig 8.2). Again, at the 3µg every 5 day 
dose, there was no significant main effect of treatment on the number of clusters, 
F(3, 49) = 1.99, p = 0.13 (see Fig 8.2). At 5µg every 10 days, there remained no 
significant main effect of treatment on cluster number, F(3, 49) = 2.01, p = 0.11 
(see Fig 8.2). Finally, at the highest dose of reelin given, 5µg every 5 days, no 
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significant main effect of treatment group on SERT cluster number was 
observed, F(3, 49) = 2.18, p = 0.10 (see Fig 8.2). 
 
 
Fig 8.2. Number of SERT clusters in lymphocyte membranes according to each 
dosage of reelin administered. (A) 3µg/ml every 10 days. (B) 3µg/ml every 5 days. (C) 
5µg/ml every 10 days. (D) 5µg/ml every 5 days. Data is presented as mean ±SEM.  
 
These findings are significant because a similar clustering pattern is 
observed in patients with depression and this particular pattern is restored with 
common antidepressants when patients are responsive to the treatment (Rivera-
Baltans et al., 2012, 2014). Hence, peripheral reelin administration appears to 
hold promising antidepressant potential through its regulation of MPC in 
lymphocytes.  
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3.5 DCX dendritic morphology 
In addition to the analysis of neurochemical alterations in the periphery, 
neurochemical alterations in the CNS, particularly the hippocampus, were also 
measured. In rodent models of chronic stress and chronic CORT treatment, and 
in patients with MDD, alterations in hippocampal neurogenesis are observed. In 
this experiment, doublecortin was used as a marker of neurogenesis. DCX is a 
microtubule-associated protein that is expressed in immature neurons in the first 
2-3 weeks of development. Figure 9 shows the schema devised by Plumpe and 
colleagues (2006), and used in the current experiment, for the categorization of 
DCX-positive cells in terms of dendritic morphology. In general, CORT treatment 
appeared to slow the maturation of DCX+ cells, with more category 1, 2, and 3 
cells, and fewer category 5 and 6 cells in the CORT-injected rats. 
 
Fig 9. Categorization of dendritic morphology according to the 6 categories of dendritic 
complexity used in this analysis. Adapted from Plumpe et al. (2006). 
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A one-way ANOVA was conducted separately for each category of neuronal 
maturation, with experimental group as the independent variable, and % of DCX+ 
cells counted as the dependent variable. Results are now reported for the % of 
DCX+ cells counted in the SGZ, collapsed across dose, for the six categories of 
neuronal maturation previously described.  
In category 1, which represents the most immature stage of neuronal 
development, there was a significant main effect of group on % of DCX+ cells, 
F(3, 70) = 3.91, p = 0.012. Post-hoc Tukey tests revealed that the CORT-Vehicle 
group showed a significant increase in the % of DCX+ cells in this immature 
stage of development, as compared to the Vehicle-Vehicle group, p = 0.026 (see 
Fig 10). The CORT-Reelin group also showed a significant increase in the % of 
DCX+ cells in category 1, as compared to the Vehicle-Vehicle group, p = 0.013 
(see Fig 10).  
In category 2, which reflects an early stage of neuronal maturation, there was 
again a main effect of group, F(3, 70) = 9.00, p < 0.001 (see Fig 10). Post-hoc 
Tukey testing showed that the CORT-Vehicle rats displayed a significant 
increase in the % of DCX+ cells compared to the Vehicle-Vehicle and Vehicle-
Reelin rats, ps = 0.004 (see Fig 10). The CORT-Reelin rats also showed a 
significant increase in the % of DCX+ cells in category 2 as compared to the 
Vehicle-Vehicle and Vehicle-Reelin rats, ps < 0.005 (see Fig 10).  
In category 3, which is considered to be an intermediate stage of neuronal 
development, there was a significant main effect of experimental group on % of 
DCX+ cells, F(3, 70) = 16.36, p < 0.001 (see Fig 10). Post-hoc testing revealed 
that the CORT-Vehicle group showed a significant increase in the % of DCX+ 
cells compared to the Vehicle-Vehicle and Vehicle-Reelin groups, ps < 0.002 
(see Fig 10). The CORT-Reelin group showed a significant increase in the % of 
DCX+ cells in category 3 compared to the Vehicle-Reelin group, p < 0.001 (see 
Fig 10). 
In category 4, also considered to be an intermediate stage of neuronal 
maturation, there was again a significant main effect of experimental group, F(3, 
70) = 3.36, p = 0.023 (see Fig 10). A post-hoc Tukey test showed that the CORT-
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Vehicle rats had a significant increase in the % of DCX+ cells compared to the 
Vehicle-Reelin rats, p = 0.040 (see Fig 10).  
In category 5, which is regarded as a more mature stage of neuronal 
development, there was a significant main effect of group, F(3, 70) = 6.14, p = 
0.001 (see Fig 10). Post-hoc Tukey analyses revealed that the CORT-Vehicle 
group had a significantly decreased % of DCX+ cells, as compared to the 
Vehicle-Reelin group, p = 0.002 (see Fig 10). The CORT-Reelin group also 
showed a significantly decreased % of DCX+ cells in category 5 as compared to 
the Vehicle-Reelin group, p = 0.011 (see Fig 10).  
Finally, in category 6, which represents the most mature stage of neuronal 
development, there was a significant main effect of group, F(3, 70) = 19.61, p < 
0.001 (see Fig 10). Post-hoc testing revealed that the CORT-Vehicle rats showed 
the expected significant decrease in the % of DCX+ cells, as compared to the 
Vehicle-Vehicle and Vehicle-Reelin rats, ps < 0.001 (see Fig 10). The CORT-
Reelin rats also showed a significant decrease in the % of DCX+ cells in category 
6, as compared to the Vehicle-Vehicle and Vehicle-Reelin rats, ps < 0.001 (see 
Fig 10).  
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Fig 10. Percentage of Doublecortin cells counted in the subgranular zone of the dentate 
gyrus for categories 1-6 of neuronal maturation. Data is presented as mean ±SEM. Lines 
represent significantly different groups. 
 
Figure 11 shows representative photomicrographs taken for each of the four 
treatment groups, demonstrating DCX+ immunolabelling in the SGZ of the DG. 
As can be seen in the following images, both the Vehicle-Vehicle and Vehicle-
Reelin groups show extensive dendritic branching, reaching into the molecular 
layer of the DG. However, the CORT-Vehicle group displays significantly reduced 
complexity of dendritic processes extending from the SGZ into the molecular 
layer. CORT-Reelin rats (for all doses of reelin administered) also shows 
diminished dendritic branching when compared to control rats.  
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Fig 11. Photomicrographs of DCX+ immunolabelling taken at 10X magnification. (A) 
Vehicle-Vehicle (B) CORT-Vehicle (C) Vehicle-Reelin (D) CORT-Reelin. Scale bar represents 
100µm.  
 
To sum up the current findings, the CORT-Vehicle rats showed an increased 
number of cells in immature stages of development and a decreased number of 
cells in more mature stages of development. This result is consistent with 
previous findings (Lussier et al., 2011, 2013; Brymer et al., in preparation). The 
addition of peripheral reelin administered alongside CORT treatment shows a 
trend for a partial restoration of neurogenesis, as illustrated by Fig. 10, but the 
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CORT-Reelin group continues to display less cell maturation as compared to 
control groups.  
 
4. DISCUSSION 
 
4.1 Implications for Behavioral Reversals Following Peripheral Reelin 
There is a continued need for faster-acting and more effective 
antidepressants. Standard antidepressant treatment is laden with poor remission 
rates, therapeutic delays, and significant side effects (Thase et al., 2005; Trivedi 
et al., 2006; Gaynes et al., 2009; Stahl, 2000). The extracellular matrix protein, 
reelin, has received attention for its association with mood and psychiatric 
disorders, including major depression.  When administered directly into the brain, 
chronic and acute reelin infusions have proven efficacious in restoring behavioral 
and neurobiological CORT-induced deficits (Brymer at al., in preparation). The 
present study aimed to determine whether peripherally-injected reelin holds 
antidepressant-like action in terms of behavioral and neurochemical parameters. 
Consistent with previous findings (Kalynchuk et al., 2004; Gregus et al., 2005; 
Johnson et al., 2006; Lussier et al., 2011, 2013; Lebedeva et al., 2017), 21 days 
of CORT treatment produced a depressive phenotype as measured by immobility 
and swimming behaviors in the forced swim test. Importantly, the addition of 
exogenous reelin restored the CORT-induced behavioral deficits to that of control 
rats, which is similar to reversals seen with other antidepressants (Fenton et al., 
2015; Rainer et al., 2012). With respect to the CORT-Vehicle rats, a full 
restoration in immobility behavior was seen with addition of reelin at all doses 
except for 5µg/ml every 10 days. Rats that received 5ug/ml of reelin every 10 
days did not display significantly reduced immobility behavior, as compared to 
the CORT-Vehicle rats. This finding is somewhat surprising, because rats that 
received lower doses of reelin (i.e., 3µg/ml every 10 days = 3µg*3 injections = 
9µg in total) and higher doses of reelin (i.e., 5µg/ml every 5 days = 5µg*5 
injections = 25µg in total) displayed complete immobility reversals. Notably, 
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however, the 5µg/ml every 10 day group did not differ from vehicle groups, 
evidencing at least a partial reversal in immobility behavior.  
In regards to swimming behavior, the CORT-treated rats spent significantly 
less time actively swimming than control rats, consistent with previous findings. 
CORT-Reelin rats that received both 3µg/ml every 5 days and 5µg/ml every 10 
days spent significantly more time swimming than CORT-Vehicle rats, evidencing 
a complete reversal in the behavioral phenotype. However, CORT-treated rats 
that received reelin at both 3µg/ml every 10 days and 5µg/ml every 5 days did 
not significantly differ from CORT-Vehicle rats. In this case, the lowest dose of 
reelin (3µg/ml every 10 days) and the highest dose of reelin (5µg/ml every 5 
days) administered did not produce a complete reversal in swimming behavior, 
while both intermediate doses (i.e., 3µg/ml every 5 days = 3µg*5 injections = 
15µg in total and 5µg/ml every 10 days = 5µg*3 injections = 15µg in total) did. 
This effect does not appear to be a result of frequency of administration because 
the two different frequencies used (every 5 days and every 10 days) were both 
successful in fully reversing the behavioral phenotype. Nonetheless, rats 
administered reelin at 3µg every 10 days and 5µg every 5 days did not 
significantly differ from vehicle groups, indicating a partial reversal in swimming 
behavior. 
In addition to the FST, the OFT was included as a behavioral index of 
locomotor activity and anxiety-like behavior. This test was included in order to 
strengthen interpretation of forced swim test findings. Prior to the current study, 
the impact of peripherally-injected reelin on behavior, including depression-like 
behavior, anxiety-like behavior, and more general behaviors, such as locomotor 
activity, was not known. Therefore, we wanted to assess whether peripheral 
reelin has an influence in other behavioral domains that could qualify our 
behavioral findings in the forced swim test. Results demonstrated no effect of 
either CORT or reelin on distance travelled (an index of locomotor activity) or 
duration spent in the inner zone of the open field arena (an index of anxiety-like 
behavior) in the OFT. This finding corroborates the interpretation that the general 
reversals in immobility and swimming behaviors in CORT-Reelin rats, as 
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compared to CORT-Vehicle rats, are attributable to a depressogenic effect of 
reelin, rather than an indirect result of reelin-induced increases in locomotor or 
anxiety-like behaviors. It is also important to note that no differences were found 
between the Vehicle-Reelin and Vehicle-Vehicle groups on any of the forced 
swim or open field behavioral measures, demonstrating that at the doses of 
reelin administered, there were no negative effects of exogenous reelin in healthy 
rats under basal conditions.  
In line with previous findings reported by other investigators, CORT injections 
at 40mg/kg administered for 21 consecutive days decreased body weight gain. 
This significant reduction in weight gain in CORT-treated rats leads to the 
question of whether the behavioral changes observed in the forced swim test 
may be a non-specific result of reduced body weight (and concomitant decrease 
in muscle mass) rather than a direct depressogenic effect of CORT. For instance, 
it may be argued that CORT-treated rats spend less time swimming and more 
time immobile due to reduced muscle mass. However, two observations suggest 
that this is not the case. First, CORT-injected rats do not display differences in 
their locomotive activity as compared to control rats, as evidenced by similar 
levels of open field exploration between CORT-injected and Vehicle-injected rats 
in the open field test, a finding that has been previously reported (Gregus et al., 
2005; Brotto et al., 2001; Kalynchuk et al., 2004; Marks et al., 2009). To further 
corroborate this observation, previous reports demonstrate that rats treated with 
repeated CORT show similar swim distances to control rats (Sousa et al., 2000). 
Second, the rescue of CORT-induced increases in immobility behavior in the 
FST by peripheral reelin did not co-occur with increases in body weight gain. 
Specifically, peripheral reelin at all doses administered did not have an effect on 
body weight gain, with both CORT-Vehicle and CORT-Reelin rats demonstrating 
similarly attenutated weight gain throughout the CORT injection period. Thus, this 
demonstrates a behavioral restoration following reelin administration that cannot 
be attributed to an indirect effect of reelin on weight gain. This is particularly 
significant as provides further support for the CORT model as a valid model for 
measuring the depressogenic effects of repeated CORT in the FST, while also 
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supporting the interpretation that reelin is impacting underlying neural circuitry 
involved in a depression-like state, and not simply affecting depression-like 
behavior via unspecific actions on body weight gain.  
Hence, the behavioral changes in the FST following CORT treatment cannot 
be attributed to changes in weight gain, but rather support the interpretation for a 
depressogenic effect of repeated CORT and the antidepressant-like action of 
peripheral reelin administration.  
 
4.2 Implications for MPC Clustering Restorations Following Peripheral Reelin 
Reelin is not only expressed in the brain, but also in peripheral tissues and in 
blood plasma (Smalheiser et al., 2000), though its roles here are much less 
understood than in the central nervous system. However, reelin-deficient mice 
show an altered pattern of protein clustering along the cell membrane of 
peripheral blood lymphocytes; specifically, an increase in the size and number of 
serotonin transporter clusters on lymphocyte membranes has been reported 
(Rivera-Baltanas et al., 2010). In the current experiment, we were motivated to 
examine SERT cluster size on lymphocyte membranes because not only is it 
altered in reelin-deficient mice, but both CORT-treated rats displaying 
depression-like behavior and patients with depression show a similar size 
increase in SERT clusters (Fenton et al., 2015b; Rivera-Baltanas et al., 2012). 
We found that CORT-treated rats showed a significant increase in the size of 
SERT clusters, as compared to control rats, with no change observed in the 
number of clusters. This effect was completely rescued with the addition of 
peripherally-injected reelin at all dosages administered. Hence, the CORT-
induced increases in the size of SERT clusters in lymphocyte membranes, a 
pattern also seen in patients with depression, were successfully rescued by 
peripheral reelin; furthermore, this rescue in SERT clustering corresponds with 
behavioral reversals on the FST. These results suggest that peripheral reelin 
administration holds promise for benefiting immune and inflammatory outcomes 
through its effects on SERT clustering in lymphocytes and the associated 
optimization of SERT functioning, as well as the associated regulation of pro-
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inflammatory cytokine release. The altered pattern of SERT clustering in 
lymphocyte membranes of rats treated with CORT presents with an increase in 
depression-like behavior, suggesting that the development of a depressive 
phenotype may be partially mediated by peripheral SERT activity. Moreover, the 
restoration by reelin of the altered SERT clustering pattern is concomitant with a 
rescue of FST behavior, suggesting that the antidepressant action of reelin may 
also be partially mediated through peripheral SERT activity. It is important to note 
that the addition of reelin in Vehicle-treated rats did not impact on the size of 
SERT clusters, indicating that reelin holds a restorative role when glucocorticoid 
levels are high, regulating the membrane clustering activity of SERT under 
pathophysiological conditions, and not under normal physiological conditions, 
thus demonstrating the potential therapeutic efficacy of exogenous reelin 
administration in the treatment of depressive symptomology.  
 
4.3 Effects of Peripheral Reelin on Hippocampal Neurogenesis 
One of the leading hypotheses in the context of depression proposes that 
prolonged stress produces hippocampal remodeling, specifically reductions in 
hippocampal neurogenesis, that play a casual role in the development of 
depression (Jacobs et al., 2000). Findings of reduced hippocampal volume in 
patients with depression (MacQueen et al., 2003; Campbell et al., 2004), as well 
as reductions in cell proliferation and survival in animal models of depression 
which are restored following antidepressant treatment (Santarelli et al., 2003), 
lend support to this hypothesis. Previous research has shown that reelin 
positively regulates adult hippocampal neurogenesis (Kim et al., 2002; Pujadas 
et al., 2010), whereas chronic CORT treatment produces potent reductions in the 
survival and maturation rates of newborn neurons (Lussier et al., 2011; 2013; 
Fenton et al., 2015). Furthermore, it has been previously shown that both chronic 
and acute intra-hippocampal reelin infusions (1µg/ul) completely reverse CORT-
induced FST immobility impairments and associated decreases in the dendritic 
complexity of immature granule cells in the hippocampus (Brymer et al., in 
preparation).  
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The current results are consistent with findings from previous studies (Fuchs 
and Gould, 2000; Pham et al., 2003; Santarelli et al., 2003; Sapolsky, 2004; 
Sheline et al., 1999; Starkman et al., 1992; Surget et al., 2008, 2011; David et al., 
2009; Wong and Herbert, 2006, 2004; Tanti et al., 2013; Ramirez et al., 2015), 
showing that many forms of chronic stress, including chronic CORT treatment, 
cause impairments in hippocampal neurogenesis. CORT-treated rats showed a 
significant increase in the percentage of DCX+ cells in categories 1, 2, 3, which 
represent the most immature stages of neuronal development, as compared to 
vehicle rats, and a decreased percentage of DCX+ cells in category 5, when 
compared to Vehicle-Reelin rats and category 6, when compared to both 
Vehicle-Vehicle and Vehicle-Reelin rats, which represent the most mature stages 
of neuronal development.  
However, our results also demonstrate that peripheral reelin did not restore 
the CORT-induced reductions in dendritic complexity. The CORT-Reelin rats 
showed a similar pattern of neuronal maturation to the pattern seen in the CORT-
Vehicle rats. Similar to CORT-Vehicle, the CORT-Reelin rats also had a 
significantly increased percentage of DCX+ cells in categories 1, 2, and 3, as 
compared to vehicle rats. The CORT-Reelin rats also showed a significantly 
decreased percentage of DCX+ cells in category 5, when compared to the 
Vehicle-Reelin rats and in category 6, when compared to both the Vehicle-
Vehicle and Vehicle-Reelin rats. Hence, results of the DCX analyses show that 
under conditions of elevated levels of glucocorticoids, peripheral reelin does not 
induce any significant reversals in the disrupted maturation rate of immature 
neurons in the hippocampus. 
 
5. CONCLUSIONS 
In summary, peripheral reelin administration reversed depression-like 
behavior, as measured by the FST, while having no effect on OFT behavior. This 
behavioral restoration by peripheral reelin may occur secondarily through brain 
changes upon crossing of the BBB, but reelin-related restorations of CORT-
induced alterations in the SERT clustering pattern suggest that reelin’s activity in 
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the periphery partially subserves its antidepressant-like effects, perhaps through 
its effects on immune system plasticity in the presence of heightened 
glucocorticoid exposure. This will be an important avenue for continued 
exploration, but the current findings demonstrate that peripheral reelin 
administration holds strong potential for facilitating stress resilience and 
protecting against the development of depressive symptomology. 
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CHAPTER 3 
General Discussion 
 
1. Overview of Main Findings 
The current experiment aimed to extend further support for the existent 
literature demonstrating that chronic CORT treatment leads to the development 
of depressive symptomology that is often accompanied with hippocampal 
alterations, namely reductions in hippocampal cell proliferation and maturation, 
which have been consistently observed using the CORT model. In addition to 
utilizing the CORT model as a rodent model of depression, the current research 
aimed to investigate the effects of the novel administration of peripheral reelin via 
the lateral tail vein in order to explore whether its antidepressant properties 
previously demonstrated by way of direct brain infusion extend to its less invasive 
peripheral administration. At this time, no other known research groups have 
peripherally injected reelin to explore its potential antidepressant-like effects. In 
addition, much less is known about peripheral reelin activity than about its roles 
in the central nervous system. Demonstration by way of peripheral reelin 
administration of a restoration in depression-like behavior brought about by 
repeated CORT would be a novel finding indicating that exogenous reelin 
administration holds promising potential for therapeutic efficacy. To this end, four 
different dosages of reelin were administered as a preliminary investigation into 
its therapeutic potential: 3µg/ml every 10 days, 3µg/ml every 5 days, 5µg/ml 
every 10 days, and 5µg/ml every 5 days.  
Another aim of the current experiment was to expand on the existent literature 
investigating alterations in the membrane protein clustering pattern of the 
serotonin transporter on peripheral lymphocytes, which has been observed with 
repeated CORT treatment, and relates to similar alterations seen in patients with 
depression. We were motivated to determine whether the intravenous 
administration of reelin could restore any CORT-induced changes in the SERT 
clustering pattern that might present with CORT-induced increases in 
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depression-like behavior. This avenue of research would begin to open up 
investigation into the mechanisms underlying reelin’s antidepressant potential.  
Finally, previous findings have demonstrated that direct infusion of reelin into 
the hippocampus, a brain structure particularly susceptible to the negative effects 
of glucocorticoids, completely reversed the CORT-induced deficits in the 
dendritic complexity of immature dentate granule cells (Brymer et al., in 
preparation). We wanted to examine whether the administration of exogenous 
reelin into the lateral tail vein could similarly reverse the hippocampal 
impairments brought about by repeated CORT exposure, and possibly elucidate 
one of the underlying mechanisms for reelin’s potential antidepressant-like 
effects. 
 
2. Effects of Chronic CORT Exposure and Addition of Exogenous Reelin 
on Depression-like Behavior 
Behavioral findings demonstrated the anticipated increase in depression-like 
behavior brought about by repeated CORT, as measured by the FST. Rats given 
40mg/kg CORT once daily for 21 consecutive days spent significantly more time 
immobile and less time actively swimming in the FST than rats given daily 
injections of saline. This increase in passive FST behavior displayed by CORT-
treated rats as compared to control rats is considered to reflect behavioral 
despair and the presence of a depressive phenotype, and is consistent with 
findings from other chronic stress and chronic CORT administration paradigms 
that utilize the FST as a measure of depression-like behavior. Importantly, in 
CORT-treated rats, the addition of exogenous reelin at 3µg/ml every 10 days, 
3µg/ml every 5 days, and 5µg/ml every 5 days, fully restored the immobility 
behavioral phenotype in the FST to levels of control rats. This reversal of CORT-
induced depression-like behavior following reelin injections, is akin to reversals 
seen with other antidepressants (Fenton et al., 2015; Rainer et al., 2012). It is not 
clear as to why rats that received the 5µg/ml every 10 day dosage did not display 
significantly reduced immobility behavior, as was seen with the other three 
dosages, but given that this dosage still did not differ from vehicle groups, at 
 80 
 
least a partial reversal in immobility behavior is evidenced. Results from the 
swimming behavioral measure of the FST show less of a consistent and robust 
pattern when compared to the immobility measure. However, for all of the 
dosages administered, CORT-treated rats spent significantly less time actively 
swimming than the vehicle group, which is again consistent with previous 
findings using the FST as a measure of learned helplessness. Importantly, at 
3µg/ml every 5 days and 5µg/ml every 10 days, reelin injections in CORT-treated 
rats caused a complete reversal in the behavioral phenotype, such that CORT-
Reelin rats spent significantly more time swimming than CORT-Vehicle rats. 
However, this difference was not observed in CORT-treated rats that received 
reelin at both 3µg/ml every 10 days and 5µg/ml every 5 days. Again, the reason 
for this distinction is unclear, but CORT-Reelin rats demonstrated comparable 
swimming behavior to vehicle groups at all dosages, indicating a partial or 
complete reversal in all cases. 
The OFT was administered as a second behavioral measure in order to 
examine changes in locomotor and anxiety-like behavior following CORT 
treatment and treatment with exogenous reelin. Findings are mixed in the 
existent literature regarding both stress and CORT effects on anxiety-like 
behavior in the open field test, with some paradigms showing stress-induced 
increases in locomotor and anxiety-like behavior (David et al., 2009; Skorewska 
et al., 2006; Ivy et al., 2008), while others show no changes (Lussier et al., 2011; 
Marks et al., 2009; Gregus et al., 2005; Kalynchuk et al., 2004; Lebedeva, 
unpublished data). For the purpose of the current experiment, it was important to 
investigate whether reelin injections could induce changes in locomotor activity or 
anxiety-like behavior that might confound interpretation of the depression 
measures evaluated using the FST. The total distance the rat traveled in the 5-
min test period served as a simple measure of locomotor activity. Results 
demonstrated no effect of either CORT or reelin on locomotor behavior in the 
OFT. This finding is important because it supports the interpretation that the 
decreased immobility time displayed by CORT-Reelin rats as compared to 
CORT-Vehicle rats, is due to a precise influence of reelin activity on the 
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development of depressive symptomology, rather than a general effect of reelin 
on locomotor activity. The duration of time that rats spent in the center zone of 
the arena in the 5-min OFT period was used to evaluate the presence of anxiety-
like behavior. Similar to that observed for total distance travelled, there was no 
effect of either CORT or reelin on this measure. Hence, addition of exogenous 
reelin in otherwise normal physiological conditions does not lead to increases in 
anxiety-like behavior as measured by the OFT. While future research should 
incorporate additional tests that measure anxiety-like behavior in order to 
corroborate this finding, the current results are important in providing initial 
support for the proposal that reelin holds antidepressant potential in the absence 
of additional negative side effects.  
There is a continued need for the development of faster-acting and more 
efficacious antidepressant treatments, given that less than 1/3 of patients with 
depression experience remission with standard antidepressant treatment, and 
only 50% achieve remission with implementation of two different 
pharmacotherapies for 6 months (Thase et al., 2005; Trivedi et al., 2006). Not 
only does it take approximately 3 weeks for patients to experience therapeutic 
efficacy with common antidepressants (Stahl, 2000), but many patients 
experience significant negative side-effects which introduces significant 
discouragement for the continuation of treatment. For such reasons, the current 
research has attempted to address an important and necessary limitation in 
pharmacotherapy development for depression. Current behavioral findings 
provide promising support for investigation into this novel avenue of 
antidepressant development.  
As mentioned, the functional activity of reelin in the periphery is much less 
understood than its roles in the brain and during development of the central 
nervous system. However, reelin is expressed in blood plasma (Smalheiser et 
al., 2000), and plasma levels of reelin have been shown to be altered in mood 
and psychotic disorders (Fatemi et al., 2001a). In reelin-deficient mice, the 
clustering of proteins along the cell membrane has been shown to be altered in 
peripheral blood cells (i.e., lymphocytes). Specifically, Rivera-Baltanas et al., 
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(2010) observed alterations in the size and number of serotonin transporter 
clusters on lymphocyte membranes in both HRM and reeler mice, which was 
particularly evident in the reeler mice, which exhibit null reelin expression. 
Moreover, rats treated with CORT for 3 weeks also show an altered pattern of 
serotonin transporter and serotonin 2A receptor clustering on lymphocyte 
membranes, as compared to control rats. An increase in FST depression-like 
behavior in these CORT-treated rats positively correlates with larger membrane 
protein clusters (Fenton et al., 2015b). Lymphocytes from patients with 
depression show a very similar increase in the size of serotonin transporter and 
serotonin 2A receptors along the plasma membrane (Rivera-Baltanas et al., 
2012). Given these findings, we were motivated to examine whether addition of 
exogenous reelin could reverse the altered pattern of SERT clustering in 
lymphocytes induced by repeated CORT treatment. In line with previous studies, 
we found that CORT-treated rats showed a significant increase in the size of 
SERT clusters, as compared to control rats, with no change observed in the 
number of clusters. Importantly, when reelin was given to CORT-treated rats, a 
complete reversal in the size of SERT clusters was observed. Furthermore, this 
reversal was found for all dosages of reelin administered. These findings are 
significant because they show for the first time that peripheral reelin can reverse 
the pattern of SERT membrane protein clustering observed in CORT-treated rats 
displaying depression-like behavior – the same pattern that is exhibited in 
patients with depression. This observation also suggests that the antidepressant-
like action of peripheral reelin in our CORT model of depression may be at least 
partially mediated by reelin’s regulation of SERT clustering in peripheral 
lymphocytes. While future studies are required to further investigate the effects of 
exogenous reelin in peripheral cells, this initial and novel finding suggests that 
peripheral reelin may hold therapeutic efficacy for the treatment of depression by 
way of restoring altered protein expression in depressed patients. 
In addition to investigating the effects of reelin administration in peripheral 
lymphocytes, we also aimed to explore whether peripheral reelin administration 
could affect aspects of brain structure and function, particularly in the 
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hippocampus, where it is known to hold important functional roles. Specifically, 
we wanted to examine whether peripheral reelin could partially restore CORT-
induced deficits in hippocampal newborn neuron maturation rate that have been 
previously observed (Lussier et al., 2011, 2013). Previous research has 
evidenced a facilitative role for reelin in hippocampal neurogenesis (Kim et al., 
2002; Pujadas et al., 2010) and previous findings from our lab have 
demonstrated that both chronic and acute intra-hippocampal reelin infusions 
(1µg/ul) completely reverse CORT-induced FST immobility impairments and 
associated decreases in the number and maturation rate of newborn neurons, 
when rats are sacrificed one week after the last reelin infusion (Brymer et al., in 
preparation). An observation of even partial restoration in neurogenesis with 
addition of reelin would provide evidence that exogenous administration of reelin 
into the bloodstream is capable of producing structural and functional 
consequences for brain functioning, whether by direct crossing of the BBB, or 
indirectly through other mechanisms. To this end, DCX, which is highly 
expressed in immature neurons in the first 2 weeks of development, was used as 
a marker of neurogenesis. Results showed the anticipated effect of chronic 
CORT treatment on hippocampal neurogenesis. CORT-treated rats showed a 
significant increase in the percentage of DCX+ cells in categories 1, 2, 3, which 
represent the earlier stages of neuronal development, as compared to vehicle 
rats, and a decreased percentage of DCX+ cells in category 5, when compared 
to Vehicle-Reelin rats and category 6, when compared to both Vehicle-Vehicle 
and Vehicle-Reelin rats, which represent the most mature stages of neuronal 
development. These results are in line with many previous studies demonstrating 
that chronic stress and chronic CORT treatment produce robust reductions in 
hippocampal cell proliferation and maturation in rodents (Fuchs and Gould, 2000; 
Pham et al., 2003; Santarelli et al., 2003; Sapolsky, 2004; Sheline et al., 1999; 
Starkman et al., 1992; Surget et al., 2008, 2011; David et al., 2009; Wong and 
Herbert, 2006, 2004; Tanti et al., 2013; Ramirez et al., 2015; Lussier et al., 2011, 
2013). The results are also not surprising given that the hippocampus is 
particularly susceptible to the negative effects of chronic stress. The 
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hippocampus contains a great number of glucocorticoid receptors and as 
mentioned earlier, there is evidence implicating a role for neurogenesis in the 
maintenance of inhibitory control over the HPA axis; neuronal projections from 
immature neurons of the ventral dentate gyrus ultimately inhibit neurons in the 
PVN to prevent the release of CRF. Reductions in neurogenesis have been 
shown to further elevate levels of glucocorticoids and exacerbate reductions in 
new neuron birth (Schloesser et al., 2009; Snyder et al., 2011). 
The examination of hippocampal neurogenesis was motivated by the goal of 
determining whether reelin administered peripherally could have effects on brain 
functions which have been implicated in depression, and may contribute to 
reelin’s antidepressant effects. Results of the DCX analysis demonstrate that 
peripheral reelin did not restore the CORT-induced reductions in dendritic 
complexity. CORT-Reelin rats showed a similar pattern of neuronal maturation as 
CORT-Vehicle rats. Specifically, CORT-Reelin rats had a significantly increased 
percentage of DCX+ cells in categories 1, 2, and 3, as compared to vehicle rats. 
CORT-Reelin rats also showed a significantly decreased percentage of DCX+ 
cells in category 5, when compared to Vehicle-Reelin rats and category 6, when 
compared to both Vehicle-Vehicle and Vehicle-Reelin rats. In spite of this 
observation, CORT-Reelin rats do show a slight increase in the percentage of 
DCX+ cells in the more advanced stages of neuronal maturation, (i.e., in 
categories 5 and 6), as compared to CORT-Vehicle rats, though this does not 
reach significance. It is possible that some reelin crossed the BBB to affect 
dendritic maturation in immature neurons, but was unable to produce any 
significant changes at the dosages given. While it cannot be determined based 
on the results of this experiment, it is unlikely that the antidepressant-like effects 
of reelin observed on FST behavior are due to an involvement of peripheral reelin 
in the maturation of newborn neurons in the hippocampus. In order to investigate 
this in the future, radioactive-tagging of the recombinant reelin protein 
administered exogenously should be considered, as it would allow for the 
determination of whether injected reelin is capable of crossing the BBB.   
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As discussed earlier on, reelin-deficient mice are more susceptible to the 
depressiogenic effects of CORT (Lussier et al., 2011), overexpression of reelin 
has been shown to protect against the development of a depressive phenotype 
(Teixeira et al., 2011), and direct infusion of reelin into the hippocampus restores 
behavioral and neurochemical deficits induced by chronic CORT treatment 
(Brymer et al., in preparation). The current behavioral, and neurochemical 
findings observed in the periphery support this previous research and a 
protective role for peripheral reelin in the face of deleterious stress effects, 
providing evidence for reelin’s antidepressant potential.  
 
3. Limitations 
 
3.1 Validity of the Repeated Exogenous CORT Model for the Study of 
Depression 
Many studies have established the exogenous CORT model as a valid tool for 
recapitulating the depressive phenotype characteristic of human depression. 
Nonetheless, the CORT model cannot provide a fully realistic simulation of the 
human disorder. One of the limiting factors of the CORT paradigm is that the 
artificial administration of exogenous CORT does not resemble the range of 
stressful experiences that take place in daily life. Furthermore, the 40mg/kg dose 
of CORT that is needed to reliably and consistently produce a depressive 
phenotype is supraphysiological, since this level of glucocorticoid release is not 
produced by natural stressors (Johnson et al., 2006).  
Such limitations are not unique to the CORT model, however; the human 
experience of depression is very difficult to reproduce and other stress models 
suffer similar shortcomings. For instance, repeated restraint stress consistently 
enforces a single physical stressor, to which animals readily adapt, and which 
does not reflect the variety of stressor types encountered in daily life. Due to the 
progressive habituation that occurs in the chronic restraint model, extensive 
variability between animals can often occur, and sometimes depression-like 
behaviors are not observed at all (Lussier et al., 2009; Gregus et al., 2005; Dunn 
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& Swiergiel, 2008). A 10-year review provides evidence that the preclinical CMS 
model can most adequately capture the human experience of depression 
(Willner, 1997), but this model is limited with difficulties of implementation, and is 
still subject to individual differences in stress susceptibility and HPA axis 
response. An advantage of the chronic exogenous CORT model is that it does 
not carry the same problems of stressor habituation and individual variability in 
stress response. Importantly, the repeated CORT model produces similar 
impairments in behavior, neuronal morphology, and neurobiology as is seen in 
human patients and in other stress models.  
In choosing an animal model of depression it is necessary to consider the 
research questions that need to be addressed, and which model can most 
efficiently address them. In the current experiment, we wanted to replicate the 
direct effects of exogenous CORT on depression-like behavior and 
neurochemical factors that have been previously observed. In using this 
approach, we could then simply and effectively evaluate the effects of reelin on 
CORT-induced behavioral and neurochemical changes, devoid of any 
habituation and psychosocial factors that could confound any effects of reelin we 
may observe. Importantly, use of the exogenous CORT model allowed us to 
effectively address this research aim.   
 
3.2 Sex-Differences in Depression-like Behavior 
Another limitation of the present study is the sole use of male Long-Evans 
rats for all testing procedures, thus limiting the generalizability of the current 
findings to the human population. This is particularly relevant given that female 
rats have been shown to have higher basal and stress-induced levels of 
circulating glucocorticoids compared to male rats (Mashoodh et al., 2008). As 
well, both glucocorticoid levels in females and processes of neuronal plasticity, 
including dendritic density of CA1 pyramidal neurons, depend upon stage in the 
estrous cycle (Carey et al., 1995; Shupnik, 2002; Wooley et al., 1990; Shors et 
al., 2001). Sex differences in behavior have also been observed following 
exogenous CORT treatment. There is evidence to suggest that female rats 
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confer greater stress resilience compared to male rats, as they display less 
depression-like behavior in the FST than males after chronic CORT exposure 
(Kalynchuk et al., 2004). This is a relevant limitation of the current study, 
because extensive literature reveals that women in their reproductive age are 
overrepresented in depression, the prevalence being approximately 2-3 times 
higher in women than men (Nolen-Hoeksema, 1987; Young et al., 1990; Kessler 
et al., 1993; Williams et al., 1995; Korstein, 1997; Bracke, 1998; Maier et al., 
1999; Frackiewicz et al., 2000). This higher prevalence normalizes once women 
reach menopause (Weissman & Olfson, 1995), suggesting that ovarian 
hormones throughout reproductive life play a role in the sex difference, as has 
been stress models incorporating female rodents. As such, it is important that 
preclinical findings can generalize to female patients as well as males.  
Given that the cyclic release of endogenous female sex hormones adds an 
extra, sensitive factor to the CORT model, we did not include female rodents in 
this preliminary investigation into the antidepressant potential of peripheral reelin 
administration. Yet, as mentioned, female rats have been shown to be 
differentially affected by CORT treatment compared to males, and as such may 
show a differential response to reelin injections in the presence of high circulating 
glucocorticoid levels. This limitation will need to be addressed in future studies in 
order to investigate reelin’s potential antidepressant actions in the opposite sex, 
and the ways in which exogenous reelin activity may be differently mediated.   
 
3.3 Validity of the Forced Swim Test for Measuring “Behavioral Despair”  
One of the major limitations concerning the FST as a measure of depression-
like behavior in rodents, is whether this behavioral despair test first developed by 
Porsolt and colleagues in 1977 actually measures what it claims to. As 
discussed, many paradigms that employ ‘depressogenic’ manipulations, such as 
chronic stress and chronic levels of glucocorticoid induction, increase the amount 
of time rats spend immobile, speed the onset to immobility, and decrease the 
amount of time rats spend actively trying to escape (Bielajew et al., 2003; 
Cancela et al., 1991; Molina et al., 1994). Furthermore, this stress-induced 
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condition of immobility that mice and rats assume in the face of escape failure, 
termed “behavioral despair”, has been consistently prevented with different 
antidepressant treatments (Porsolt et al., 1977, 1978; Borsini et al., 1989; Cryan 
et al., 2005; Detke et al., 1997), yet some criticisms have been made regarding 
the FST as a test of behavioral despair indicative of a depressive phenotype.  
As discussed earlier, the FST protocol used by Porsolt and colleagues (1977) 
included a pretest immersion trial followed by a subsequent immersion test. 
During the immersion test, Porsolt found that the onset to immobility was much 
more rapid, interpreted as “behavioral despair”, with the reasoning that the 
animal had realized escape was impossible. However, there is also evidence to 
suggest that the immobility behavior displayed by mice and rats in the FST is not 
reflective of “despair”. O’Neill and Valentino (1982) questioned this assumed 
relationship between inescapability and immobility when they found that there 
was no difference in immobility time during the test period between animals 
which had been able to escape during the pretest and those which had not been 
able to. Borsini and colleagues (1986) used Porsolt’s version of the forced swim 
test to show that rats behave quite differently depending on the levels of water 
(or no water) used in both pretest and test sessions. Regardless of the pretest 
condition, immobility time was not affected during the test period when rats were 
placed in just 4 cm of water, a finding that is in opposition to the learned 
helplessness, and hence “despair”, that Porsolt argued would be produced. 
Instead, Borsini et al. (1986) suggest that it is familiarity with the environment 
rather than despair that affects immobility, since even rats that were pre-exposed 
to an empty cylinder prior to test spent more time immobile in 15 and 30 cm of 
water as compared to rats that were not pre-exposed. In spite of this, familiarity 
with the environment does not appear to be the only factor, since no difference in 
immobility was found during test in 4 cm of water between rats with prior 
environmental experience and those with none. Instead, it is suggested that the 
presence of “fear” or a “life-threatening experience” in rats exposed to greater 
water depths plays a role in immobility time, since regardless of pretest condition 
rats exposed to 15 and 30 cm of water climbed, jumped, and dived the most, with 
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the most vigorous activity seen in the 30 cm water condition. These results offer 
an alternative interpretation to immobility behavior in the FST – one that suggests 
immobility in water is caused by a feeling of danger in a recognizable 
environment, rather than a sense of despair – and are supported by research 
proposing immobility behavior as an adaptive stress response (Hawkins et al., 
1978). While it is important to remain critical in the interpretation of animal 
behavioral measures that attempt to model complex aspects of human disorders, 
the fact that the FST is consistently responsive to multiple classes of 
antidepressant drugs and non-pharmacological antidepressant treatments, 
including transcranial magnetic stimulation, REM sleep deprivation, and 
electroconvulsive shock (Borsini & Meli, 1988), supports its validity in the 
development of novel antidepressants. Future work should continue to explore 
reelin’s antidepressant potential by incorporating multiple behavioral tests 
alongside the FST, in order to measure a range of depression-like behavior and 
strengthen the current findings.  
 
3.4 Limitations of the Reelin-Injection Paradigm 
One of the concerns that arose when evaluating the efficacy of the paradigm 
used for reelin injections was a concern regarding the stressful effects of the 
reelin injection procedure itself. The experience of being placed in the restraint 
device, having blood taken, and receiving a tail vein injection, introduced an 
added stressor for rats already subjected to the CORT paradigm. In addition, 
some rats required more pricks, and hence longer time spent in the restrainer, in 
order to access the vein and administer the reelin. This inconsistency may have 
introduced greater variability between rats. However, at the outset of the 
experiment, control measures were taken in order to address this foreseen 
concern. Specifically, all appropriate control groups were included in the 
experimental design (i.e., Vehicle- and CORT- treated rats that received 
intravenous saline injections every 5 and 10 days in order to match both 
frequencies of reelin administration). This was done to control for confounding 
effects of time spent in the restraint device. On this note, Vehicle-treated rats that 
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received IV saline every 10 days, and Vehicle-treated rats that received IV saline 
every 5 days did not significantly from each other in their depression-like 
behavior in the FST or their anxiety-like behavior in the OFT. Furthermore, an 
additional two groups of rats were included in the experiment, which received 
subcutaneous CORT or Vehicle injections, but did not receive lateral tail vein 
injections in the restraint device. The data from these two groups of rats was not 
included in the reported findings, because these rats were added as a 
precautionary measure in order to evaluate any potential impact of the restraint 
device on behavior. We found that Vehicle- and CORT-treated rats that did not 
undergo the lateral tail vein procedure, and Vehicle- and CORT-treated rats that 
did receive intravenous saline injections in the tail vein did not significantly differ 
from each other in their depression-like or anxiety-like behavior. This signifies 
that exposure to the restraint device and the tail vein injection procedure itself, 
whilst likely a stressful experience, did not have any significant impact on 
behavior that could confound the current results. Despite this, future research 
should consider measuring basal circulating glucocorticoid levels and 
glucocorticoid levels following the injection period, in order to determine whether 
exposure to the restraint device significantly impacts glucocorticoid release. 
 
4. Future Directions 
 
There are several important directions that future work should take in order to 
strengthen and develop the current model. First of all, multiple behavioral tests 
should be conducted in order to gain a broader understanding of exogenous 
reelin’s antidepressant-like effects, as well as its potential influence on memory 
processes. As mentioned earlier, reelin holds important facilitative roles in the 
hippocampus, including the facilitation of long-term memory formation. Recent 
work in our lab found that intra-hippocampal reelin infusions (1µg/ul) directly into 
the dorsal hippocampus completely restored the CORT-induced impairment in 
hippocampal-dependent object-location memory. It will be important to explore 
whether IV reelin injections similarly hold a protective role for hippocampal-
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dependent memory in the face of deleterious CORT effects. To address this, 
future work should look to incorporate the object-location memory test as well as 
other hippocampal-dependent tasks that are sensitive to chronic CORT 
exposure, such as the Morris Water Maze. It will also be important to employ 
behavioral tests that can provide additional measures of depression-like 
behavior, in order to examine the potential impact of exogenous reelin on other 
depression-like symptoms. In this vein, the sucrose preference test could provide 
a valuable measure of anhedonia, a cardinal symptom of depression.  
As discussed, the prevalence of depression is approximately 2-3 times higher 
in women than in men, and stress models with female rodents demonstrate that 
females are affected differently than males in terms of both behavior and 
neurobiology. For this reason, it is particularly relevant to explore gender 
influences in the reelin injection paradigm under conditions of chronic CORT 
treatment, on both depression-like and anxiety-like behaviors as well as on 
underlying neurobiology.  
Based on previous findings reporting an altered pattern of SERT clustering on 
lymphocyte membranes in both patients with depression and in reelin-deficient 
mice and CORT-treated rats, we focused our analysis on this transporter in the 
present study. However, future work should begin to explore additional 
transporters, such as the dopamine transporter, to determine how their clustering 
patterns in peripheral blood cells may be impacted by increased glucocorticoid 
levels and addition of reelin. This vein of research opens up investigation into the 
neurobiology underlying reelin’s amelioration of depression-like behavior. The 
identification of various neurochemical markers is important in order to guide 
future investigation into the underlying mechanisms that contribute to negative 
stress effects and the restorative effects of reelin.  
At the same time, it would be valuable to look at the parallel and temporally 
dynamic effects of CORT and reelin on the development, expression, & 
progression of depression-like symptoms in rodents, and the regionally-specific 
mechanisms that might be having an influence. To this end, behavioral testing 
can be incorporated throughout the CORT and reelin injection period to examine 
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whether acute doses of reelin can protect against the progressive development 
of CORT-induced deficits. Blood sampling can be acquired at corresponding time 
points so that in addition to examining any protective effects of reelin on 
behavior, we can see how these effects may coincide with alterations in 
peripheral transporters, allowing us to more confidently ascertain the 
mechanisms underlying the antidepressant-like effects of exogenous reelin. 
As briefly mentioned earlier, reelin has been shown to be expressed in 
endothelial cells of the BBB (Perez-Costas et al., 2015), but whether reelin is 
able to cross the BBB is still not known. While results from the current 
experiment evidence that peripheral reelin impacts FST behavior, they do not 
provide any indication that reelin crossed the BBB to do so. This will be important 
to determine in future research, as the crossing of the BBB means that reelin can 
directly impact brain changes to have neuroprotective effects. Radioactive-
tagging of the recombinant reelin protein prior to injection in the lateral tail vein 
would allow subsequent identification of the injected protein via 
immunohistochemical analyses. This would ultimately allow the determination of 
whether or not reelin reached the brain. 
 
 
5. Conclusions 
 
The main aim of the current experiment was to determine, for the first time, 
whether reelin administered peripherally holds antidepressant-like action, without 
negatively impacting in other domains. The second aim of the experiment was to 
examine whether two neurobiological markers, hippocampal cell maturation and 
pattern of serotonin transporter clustering in peripheral lymphocytes, both of 
which are implicated in the context of depression, are positively impacted by the 
addition of peripheral reelin following a period of prolonged exposure to stress 
hormone. All doses of reelin administered reversed the depression-like behavior 
brought about by treatment with stress hormone, while restoring the associated 
changes observed in serotonin transporter clustering in lymphocyte membranes. 
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These findings demonstrate the antidepressant potential of reelin administered 
peripherally. In conclusion, the preclinical body of research outlined in this thesis 
provides novel and valuable findings that hold strong potential for addressing the 
limitations inherent in current pharmacotherapeutic treatments with standard 
antidepressants.   
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